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Abstract of thesis
Overt autoimmune hyperthyroidism and hypothyroidism were found
three times more commonly in insulin-dependent than in non-insulin-
dependent diabetics. Similarly, clinically unrecognised primary autoim¬
mune thyroid failure, as evidenced by elevation of the serum thyrotro¬
phs concentration, was twice as common in insulin-dependent as in non-
insulin-dependent diabetics. In contrast to the general insulin-
dependent diabetic population, insulin- dependent diabetics with overt
and clinically unrecognised autoimmune thyroid disease were character¬
istically female and middle-aged at the onset of diabetes. Ages at
onset of diabetes and of thyroid dysfunction were correlated, suggesting
the possibility of a common and coincident pathogenesis. Insulin-
dependent diabetics with coexisting autoimmune thyroid disease showed a
higher prevalence of HLA-B8, cytoplasmic and complement-fixing islet
cell antibodies than those without thyroid disease. Within the
insulin-dependent diabetic population, retinopathy was not related to
the coexistence of autoimmune thyroid disease.
In diabetics with elevated serum thyrotrophin concentrations but
serum total thyroxine concentrations within the normal range, hypothy¬
roidism developed at a rate of 5% per annum in patients with thyroid
microsomal antibodies.
Thyroid disease was more common in siblings of diabetics with
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thyroid disease than in those of diabetics without thyroid disease.
Insulin-dependent diabetes was more common in siblings of diabetics with
a personal or family history of thyroid disease than in those of diabet¬
ics without such a history. In contrast to the younger, male, insulin-
dependent patients, diabetics with coexistent autoimmune thyroid disease
showed no seasonal variation in incidence. Thus, the pathogenesis of
diabetes, when associated with autoimmune thyroid disease, appears to be
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(1) Classification of diabetes mellitus.
Before the discovery of insulin, diabetics selected themselves into
two groups - those who acquired symptoms acutely, rapidly lost weight,
developed ketoacidosis and died, and those who developed symptoms insi-
duously, were commonly overweight and usually survived many years having
severely restricted their carbohydrate intake. Age at onset was evi¬
dently a further distinguishing feature since the former group was usu¬
ally younger than the latter. The discovery of insulin led to the gen¬
erally accepted clinical distinction between insulin-dependent diabetics
and non-insulin-dependent diabetics which, unfortunately, ceded to the
more popular differentiation of diabetics into juvenile - and maturity -
onset. This was a classification with neither reference to diabetic
treatment nor aetiology.
In the early 1970xs, all diabetics were considered to suffer from
the same disease of homogeneous aetiology but of variable severity and
age at presentation. Preliminary evidence in support of an aetiological
distinction between insulin-dependent diabetes and non-insulin-dependent
diabetes derived from the examination of families of insulin-dependent
and non-insulin-dependent diabetics. McDonald (1974) reported equal
prevalence of diabetes in grandparents of juvenile- onset, insulin-
dependent diabetics and in grandparents of non-diabetic, age-matched
controls and subsequent family studies (Irvine et al, 1977c; Cudworth,
1978) suggested that insulin-dependent and non-insulin-dependent dia-
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betes "breed true". Confirmation that predispositions to insulin-
dependent and non-insulin- dependent diabetes are inherited separately
was provided by comparisons of concordance rates for each type of dia¬
betes in monozygotic and dizygotic twins (Barnett et al, 1981).
Comparison of the distribution of HLA antigen frequencies in
insulin- dependent and non-insulin-dependent diabetics (Nerup et al,
1974; Cudworth and Woodrow, 1976) showed several significant differ¬
ences, with family studies (Walker and Cudworth, 1980) confirming asso¬
ciation of specific HLA antigens with insulin-dependent but not with
non-insulin-dependent diabetes. Since the immune response genes may
exist within the HLA system these findings provided support for the view
that the aetiology of insulin-dependent diabetes, but not non-insulin-
dependent diabetes, might have an immunological basis. Evidence in
favour of this concept also derived from the demonstration of humoral
(Bottazzo et al, 1974; MacCuish et al, 1974a) and cellular (Nerup et
al, 1971; 1973; MacCuish et al, 1974b) sensitivity to pancreatic
antigens in insulin-dependent diabetics. Lastly, epidemiological stu¬
dies suggested that the onset of insulin-dependent diabetes, but not
non-insulin-dependent diabetes, might be related to environmental influ¬
ences (Adams, 1926; Gamble and Taylor, 1969).
With the acknowledgement of an aetiological distinction between
non-insulin- dependent and insulin-dependent diabetes, it became
apparent that a small proportion of diabetics treated without insulin
exhibited HLA, immunological, familial and metabolic characteristics
typical of insulin-dependent diabetics. Many of these patients ulti¬
mately became insulin-dependent (Irvine et al, 1977a)and it was there-
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fore suggested (National Diabetes Data Group, 1979) that those diabetics
having the characteristics of insulin-dependent diabetes be described as
type 1 diabetics, whilst those having the characteristics of non-
insulin-dependent diabetics be described as type 2 diabetics, irrespec¬
tive of current dependency on insulin.
Classification of auto-immune thyroid disease.
Hashimoto*s Thyroiditis
This condition is characteristically found in middle-aged female
patients who present, clinically, with a firm, painless, symmetrical
goitre often accompanied by a variable degree of primary thyroid
failure. The histology of the gland is dominated by diffuse lymphocytic
infiltration, commonly leading to the formation of lymphoid follicles
(Hashimoto,1912). The cellular infiltrate includes plasma cells, lym¬
phocytes and often Askanazy cells (Lindsay et al, 1952; Woolner et al,
1959). Fibrosis is frequently present to a varying degree. The paren¬
chyma is often lobulated with a reduction in the number of follicles
which may be small, containing little colloid, but may also show hyper¬
plasia. Immunofluorescence studies (Calderon et al, 1973) have shown
the presence of antibodies attached to the basement membrane of the fol¬
licular cells and these may include thyroid-growth immunoglobulins
(Drexhage et al, 1980). A variety of circulating antibodies may be
demonstrated including antibodies to thyroglobulin, thyroid colloid and
microsomes, and thyroid-growth immunoglobulins.
Primary atrophic hypothyroidism
This is again a condition most commonly found in middle-aged women
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presenting with primary thyroid failure unaccompanied by a goitre. Over
and above a modest lymphocytic thyroid infiltration and circulating thy¬
roid antibodies usually associated with Hasimoto^s thyroiditis, this
condition is characterised by fibrous atrophy of the thyroid gland,
probably due to the production of antibodies (Drexhage et al, 1981)
capable of blocking the action of thyroid- growth immunoglobulins,
thyroid-stimulating immunoglobulins and thyrotrophin (TSH).
Gravesv Disease
The clinical features of this condition are the result of hyper¬
secretion of thyroid hormones commonly occurring, again, in middle-aged
women, many of whom have a goitre. It is associated with the production
of human-specific thyroid-stimulating immunoglobulin (Orgiazzi et al,
1976) which cross-reacts with the TSH receptor on the surface membrane
of the thyroid cell and which stimulates hyperthyroidism. The goitre
may develop as a result of concomitant production of thyroid- growth
immunoglobulins (Drexhage et al, 1980) which probably recognise separate
antigenic sites on the thyroid cell surface. The histology of the gland
reveals hyperplastic follicles with scalloping of the colloid material
contained within, and an inconsistent, low-grade lymphocytic infiltra¬
tion.
Each of these three conditions may be accompanied by ophthalmic
pathologies, pre-tibial myxoedema and thyroid acropachy, each of which
may have an immunological aetiology. Moreover, an individual patient
may develop each of these conditions in sequence. Thus, patients have
been described (Irvine et al, 1979) as suffering from primary autoimmune
thyroid failure followed by Graves' disease, while a substantial
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proportion of patients treated medically for Graves' disease subse¬
quently develop thyroid failure with or without a goitre (Irvine et al,
1977b). Lastly, approximately 25% of Hashimoto goitres disappear com¬
pletely with thyroid atrophy and fibrosis after prolonged replacement
with thyroxine treatment.
It is possible that a proportion of simple, non-toxic goitres are
also immunologically derived and are the consequence of the action of
thyroid- growth immunoglobulins on normal thyroid tissue. Furthermore,
a proportion of multinodular goitres are said to show evidence of thy¬
roid specific humoral and cellular autoimmunity (Mota et al, 1980)
although these findings have yet to be confirmed. Nevertheless, the
term autoimmune thyroid disease will hereafter be restricted to the
three conditions described above - Hashimoto^s thyroiditis, primary
atrophic hypothyroidism and Graves' disease.
(2) Common and contrasting features of type 1 diabetes and auto-immune
thyroid disease.
Histology
Inflammation of islet tissue taken from young diabetics dying
shortly after the development of ketotic diabetes was first described as
"insulitis" by Von Meyenburg in 1940. Affected islets are usually
atrophic and infiltrated to a variable degree with large mono-nuclear
cells, sometimes polymorphs and very rarely eosinophils. Plasma cells
are conspicuous by their absence. The islet capsule is commonly sur¬
rounded by a halo of lymphocytes, extending within the periphery of the
islet and cuffing capillaries in the stroma (Warren et al, 1966). Occa-
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sionally, the lymphocytic infiltration of the islet parenchyma is par¬
ticularly florid (Gepts, 1965). Within a year of the onset of diabetes,
the inflammatory infiltrate of the islet is no longer seen and the beta
cells are atrophied to extinction.
Whereas the histological features of insulitis are fairly uniform,
depending largely on the stage of development of the lesion, the histo¬
logical appearances of thyroid tissue vary according to the nature of
the underlying autoimmune thyroid disease. The appearances of the thy¬
roid gland in patients with atrophic hypothyroidism are similar to those
of the latter stages of insulitis and one might envisage a greater simi¬
larity if thyroid tissue were available in the early stages of the
natural history of this condition. In contrast, the histological
features of Hashimotovs thyroiditis and Graves* disease may be dis¬
tinguished from those of insulitis by the florid lymphocytic and plasma
cell infiltrates on the one hand, and by parenchymal hypertrophy on the
other hand.
Humoral Immunity
Antibodies reactive with a cytoplasmic antigen common to all pan¬
creatic islet cells (Bottazzo et al, 1974; MacCuish et al, 1974a) are
present in low titre in most type 1 diabetics at/or pre- diagnosis
(Irvine et al, 1976; 1977e). The titre of antibody usually falls
within months of the diagnosis of diabetes (Irvine et al, 1977e). Com¬
plement fixing antibodies specific for pancreatic beta cells have also
been described (Bottazzo et al., 1980). Similarly, patients with
autoimmune thyroid disease commonly have circulating antibodies to thy¬
roid microsomes, colloid and thyroglobulin. Such thyroid and islet cell
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antibodies may not themselves by cytotoxic and may therefore be of lit¬
tle functional significance. On the other hand islet cell surface anti¬
bodies have been described (Lernmark et al., 1978; Freedman et al.,
1979) which preferentially bind to the beta cell and are found to corre¬
late with islet cell cytotoxic antibodies which are complement-binding
(Dobersen et al., 1980). Complement-binding beta cell surface antibo¬
dies may impair the release of insulin from those cells in response to
glucose (Kanatsuna et al., 1981; Sai et al., 1981). Antibodies capable
of influencing pancreatic islet cell function have yet to be described
(other than those causing direct cell damage) in diabetics, whereas
antibodies capable of stimulating the thyroid, blocking the TSH receptor
and promoting thyroid growth have all been documented in patients with
autoimmune thyroid disease (Orgiazzi et al., 1976; Zacharija et al.,
1980; Drexhage et al., 1980).
Lastly, immune complexes have been described in the serum of
patients with autoimmune thyroid disease (Calder et al., 1974) and in
type 1 diabetics (Di Mario et al., 1980). It has been suggested (Calder
et al., 1975; Irvine et al., 1978a) that K cells, armed with immune
complexes, may be responsible for the tissue damage sustained by each
cell type (i.e. insulitis and thyroiditis), resulting in type 1 diabetes
and hypothyroidism, respectively.
Cell-Mediated Immunity
The proportion of circulating T and B lymphocytes in type 1 diabet¬
ics is normal' (MacCuish et al., 1974c), suppressor T cell activity is
reduced (Pozzilli et al., 1983) while K cell activity is increased (Poz-
zilli et al., 1979). Leucocytes from type 1 diabetics exhibit
- 14 -
hypersensitivity to pancreatic antigen as demonstrated by migration
inhibition studies (Nerup et al., 1971; 1973; MacCuish et al., 1974b).
Intra-cutaneous injection of a homogenate of duct-ligated porcine pan¬
creas has been shown (Nerup et al 1971) to induce a delayed-type hyper¬
sensitivity reaction in a small group of type 1 diabetics who showed
leucocyte migration inhibition in response to the same antigen. Lympho¬
cytes from newly presenting type 1 diabetics show significant transfor¬
mation when challenged with bovine and porcine insulin in apparently
half the patients thus tested (MacCuish et al., 1975).
Parallel studies in patients with autoimmune thyroid disease have
yielded similar findings. Thus, the proportion of T and B lymphocytes
is similar to that found in controls (Urbaniak et al., 1974; Calder et
al., 1976), while suppressor T cell function is impaired (Okita et al.,
1981) and K cell activity increased (Calder et al., 1976). Leucocyte
migration inhibition tests are positive in response to thyroid antigens
in patients with Hashimoto^s thyroiditis and Graves'1 disease (Soberg and
Hallberg, 1968; Calder et al., 1972; Lamki et al 1973). Greater
migration inhibition is found in Hashimoto patients whose goitre fails
to respond to thyroxine treatment (Wartenberg et al., 1973). Intracu¬
taneous injection of thyroid extract in patients with Hashimoto^s thy¬
roiditis will induce a delayed hypersensitivity reaction (Buchanen et
al., 1958; Soberg and Hallberg, 1968). Lymphocytes from Hashimoto's,
but not Graves'1 disease patients have been shown to undergo blast
transformation on exposure to thyroglobulin (Lycette and Pearman, 1965;
Ehrenfeld et al., 1971; Delespesse et al., 1972). Lymphocytes from
patients with Hashimoto^s disease are cytoxic to thyroid cell monolayers
(Laryea et al., 1973), chicken red blood cells coated with thyroglobulin
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(Calder et al., 1973) and heterologous cells coated with thyroglobulin
and thyroid microsomes (Podleski, 1972).
It should be noted that most studies of cell-mediated immunity in
autoimmune thyroid disease have concentrated on patients with
Hashimoto's thyroiditis. Inconsistent findings in relation to Graves'
disease may reflect varying degrees of disease activity. Patients with
atrophic hypothyroidism have not received the same attention although
within the spectrum of autoimmune thyroid disease, they may represent
the closest pathological analogy to the insulitis of type 1 diabetes.
HLA Analyses
Population studies (Cudworth et al., 1982) have shown an increased
incidence of two distinct HLA axes in the insulin-dependent diabetic
population, DW4, DR4, A2, BW62, CW3 and DW3, DR3, Al, B8, CW7. The
former axis tends to be associated with an earlier age at onset, high
insulin antibody titres and possibly an increased risk of microan¬
giopathy (Dornan et al., 1982). The latter tends to be associated with
low insulin antibody titres and relative protection from development of
microangiopathy. Family studies confirm segregation of HLA type and
predisposition to insulin-dependent diabetes within affected families,
as might be anticipated (Cudworth et al., 1982).
The HLA axis DW3, DR3, Al, B8 is over represented in patients with
Graves' disease (McMichael et al., 1975; Thorsby et al., 1975) and pri¬
mary atrophic myxoedema (Irvine et al., 1978b; Moens et al., 1979)
whereas DR5 has been shown to be associated with Hashimoto's thyroiditis
(Weissel et al., 1980). Further heterogeneity has been demonstrated
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within the population of patients with Graves' disease. Thus, those
whose condition tends to relapse following medical treatment are more
commonly DR3, A1, B8 than those remaining in remission (Irvine et al.,
1977d; Bech et al., 1977). Similarly, coincident ophthalmopathy is
associated with DR3, B8 in patients with Graves' disease (Schleusener et
al., 1983).
Familial Predisposition
Acceptance of the aetiological distinction between type 1 and type
2 diabetes has simplified the interpretation of studies of inheritance
of diabetes. Thus, twin studies show (Barnett et al., 1981) that
approximately half of monozygotic twins are concordant for insulin-
dependent diabetes, whereas non-identical twins exhibit a much lower
concordance rate of approximately 10%, confirming the strength of the
genetic predisposition to type 1 diabetes. Examination of the pre¬
valence of insulin-dependent diabetes in first degree relatives of
insulin-dependent diabetics (Walker et al., 1980; Wagener et al., 1982;
Kobberling et al., 1980) shows the risk to be approximately similar in
siblings (3.3 - 5.7%), parents (2.6%) and children (1.5%).
Twin studies have yielded parallel confirmation of the inherited
predisposition to Graves' disease (Harvald and Hauge, 1956; Hassan et
al., 1956), Hashimoto's thyroiditis (Irvine et al., 1961; Zaino and
Gerra, 1964) and primary atrophic hypothyroidism (Hennen and Dodinval,
1965). The concordance rate for Graves' disease is of the same order as
that found for insulin-dependent diabetes (Harvald and Hauge, 1956;
Hassan et al., 1956; Vogel, 1959), while figures for Hashimoto's
disease and primary atrophic hypothyroidism are not yet available.
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Family studies also indicate an increased risk of autoimmune thyroid
disease in close relatives of patients with Graves* disease (Bartels,
1941; Martin and Fisher, 1945; Howel-Evans et al., 1967), primary
atrophic hypothyroidism (Hall, 1967) and Hashimoto*s thyroiditis (Hall
and Stanbury, 1967; Chopra et al., 1977). Indeed, the risk of thyroid
disease in close relatives of propositi with autoimmune thyroid disease
appears to be approximately twice that for insulin-dependent diabetes in
relatives of insulin-dependent diabetics.
A further important difference between the patterns of inheritance
of insulin-dependent diabetes and autoimmune thyroid disease is that the
sexes are approximately equally represented in affected relatives of
insulin- dependent diabetics who themselves show roughly equal sex
incidence. In contrast, affected relatives of subjects with autoimmune
thyroid disease exhibit marked female preponderance, as do the pro¬
bands, irrespective of type of auto immune thyroid disease.
The prevalences of islet cell and thyroid antibodies are increased
in close relatives of insulin-dependent diabetics (Irvine et al., 1977e;
Gorsuch et al., 1981; Ginsberg-Fellner et al., 1982) and patients with
auto-immune thyroid disease (Howell-Evans et al., 1967; Chopra et al.,
1977; Hall et al., 1960; Mather et al., 1980), respectively. Once
again, islet cell antibody positive relatives show a sex ratio of
approximately 1:1, whereas thyroid antibody positive relatives show
female preponderance.
The modes of inheritance of insulin-dependent diabetes and of
autoimmune thyroid disease remain undefined. It is thought likely that
a polygenic mode of inheritance rather than a simple autosomal dominant
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or recessive mode of inheritance may be operative.
Aetiology and the Environment
Seasonal variation in the incidence of juvenile-onset type 1 dia¬
betes was first reported by Adams (1926) and subsequently confirmed by
Gamble and Taylor (1969). These observations, together with the rela¬
tionship between peaks in age incidence of type 1 diabetes and exposure
to new school environments (Gamble et al., 1973) led to the hypothesis
of a viral aetiology for type 1 diabetes. Further support for this
hypothesis has derived from the temporal clustering of onset of type 1
diabetes in twins (Nelson et al., 1975) and sibships (Gamble, 1980).
Direct evidence for a viral aetiology is provided by reports of type 1
diabetes following specific viral infections (Burgess et al., 1974;
Forrest et al., 1971; Yoon et al., 1979) and by an increased prevalence
of Coxsachie B4 antibodies in established type 1 diabetics (Gamble et
al., 1969). Certain viruses may be demonstrated (Craighead and McLane,
1968) to be beta cytotropic and to cause insulitis analogous to that
seen in human type 1 diabetics. Of further interest, is the observation
that the susceptibility to insulitis depends on genetic factors as well
as prior exposure to streptozotocin (Toniolo et al., 1980) and testos¬
terone (Helgason and Jonasson, 1981; Helgasson et al., 1982). Other
environmental agents implicated in the pathogenesis of type 1 diabetes
include rodenticides (Karam et al., 1980) and N-nitroso compounds (Hel¬
gason and Jonasson, 1981; Helgason et al., 1982).
By contrast, the evidence for an environmental pathogenesis of
autoimmune thyroid disease is lacking (Hadden and McDevitt, 1974). An
unconfirmed report (Volpe, 1979) suggested there to be an increased
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frequency of antibodies to influenza B and mumps viruses in thyrotoxic
patients. Whereas systemic viral infections are not uncommonly accom¬
panied by self- limiting subacute thyroiditis, established autoimmune
thyroid disease very rarely follows such an illness (Joasoo et al, 1975;
Werner, 1979). Isolation of viral particles from diseased thyroid tis¬
sue has not been convincingly demonstrated despite the wealth of avail¬
able material obtained surgically. A single report (Farid et al., 1980)
of a seasonal incidence of HLA-B8 positive Gravesxdisease remains uncon¬
firmed. Other environmental agents are likely to account for only the
small minority of cases of thyroid disease. While "stress" is fre¬
quently implicated in the pathogenesis of Gravesv disease, direct evi¬
dence in favour of such a pathogenesis is lacking (Hadden and McDevitt,
1974). In the face of cumulative evidence against an environmental
cause of autoimmune thyroid disease, the fact remains that only approxi¬
mately half the monozygotic co-twins of patients with Graves * disease or
thyroiditis develop the same condition. Moreover, there are reports of
one twin developing Graves' disease while the other develops thyroiditis
(Jayson et al., 1967; Kidd et al., 1980). Thus, non-genetic factors
must influence the probability of developing these conditions although
the responsible agent(s) remain undetermined.
Animal Models
A number of naturally occuring animal models of type 1 diabetes
have been described. The BB/W rat emerged as a spontaneous mutation
within a breeding colony. Approximately half of such animals develop
insulin-dependent diabetes at 60-180 days of age and may be found to
have a round cell pancreatic islet infiltrate (Nakhooda et al., 1976).
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They are immunologically incompetent (Naji et al., 1981; Bellgrau et
al., 1982) while neonatal thymectomy or immunosuppression with anti-
lymphocytic serum prevents the development of insulitis/diabetes (Like
et al., 1979; 1981). BB/W rats raised in a sterile gnotobiotic
environment develop diabetes with a frequency similar to that observed
in an unprotected environment (Rossini et al., 1979). Although this
does not exclude the possibility of a vertically transmitted infective
agent, e.g. virus, being responsible for the pathogenesis of insulitis,
it is possible that this animal model represents a pure autoimmune
disease, being independent of environmental influences. A similar
pathogenesis has been offered as cause of the insulitis found in the NZB
mouse which develops other autoimmune phenomena such as lupus and
nephritis (Melez et al., 1980; Kolb et al., 1980).
Insulitis may also be induced in animals by immunisation of hetero¬
logous or homologous insulin (Le Compte et al., 1966; Grodsky et al.,
1966) with Freund"s adjuvant or injection of endocrine pancreas with
Freund"s adjuvant. Passive immunisation by injection of heterologous
anti-insulin serum will also induce insulitis (Lacy et al., 1965).
Spontaneous development of thyroiditis occurs in the Obese strain
of white Leghorn (OS) chickens whose thyroid histology closely resembles
that of Hashimoto"s thyroiditis. Such animals have circulating thyro-
globulin antibodies whose titre correlates with severity of disease
(Wick et al., 1974). Local production of thyroglobulin antibody by
plasma cells infiltrating the thyroid gland has been demonstrated
(Schauenstein and Wick, 1974). In contrast to the BB/W rat, neonatal
thymectomy enhances the degree of thyroiditis whereas bursectomy reduces
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the severity of the thyroiditis. Spontaneous autoimmune thyroiditis,
whose histology is similar to that of Hashimoto's thyroiditis, is also
reported in closed colonies of Beagle dogs, (Fritz et al., 1970) thymec-
tomised and whole-body X-irradiated Wistar rats (Penhale et al., 1973)
and Buffalo strain rats (Glover and Reuber, 1968). Lastly, the BB/W rat
is also recognised to develop thyroiditis spontaneously, and concomi¬
tantly with insulitis (Sternthal et al., 1981).
Immunisation with thyroid extract will induce experimental thy¬
roiditis having characteristic thyroid histology, circulating thyroglo-
bulin antibodies and delayed-type skin reactions to thyroglobulin (Wick,
1975). In contrast to the cellular infiltrate of Hashimoto's thy¬
roiditis and the spontaneous thyroiditis of OS chickens, plasma cells
and germinal centres are rarely seen, while microsomal antibodies are
only found in the monkey animal model (Andrada et al., 1968). An exper¬
imental model of Graves' disease has yet to be described.
(3) Conclusions and aims of thesis.
Type 1 diabetes and autoimmune thyroid disease thus share very many
characteristics. They have similar histologies, humoral and cellular
immune characteristics, HLA antigen distributions, and familial
predisposition, while animal models exhibit parallel features and even
coexisting insulitis and thyroiditis. Nevertheless, several striking
differences are evident between these two conditions. Thus, whereas the
evidence in favour of an environmental precipitant to the pathogenesis
of type 1 diabetes is irrefutable, no such reliable evidence yet exists
in respect of autoimmune thyroid disease. Alternatively, the familial
risk of autoimmune thyroid disease appears to be considerably stronger
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than that of type 1 diabetes, and whereas female preponderance is
characteristic of subjects with autoimmune thyroid disease, the sexes
are approximately equally represented when considering type 1 diabetics.
Type 1 diabetes is predominately a disease of childhood or adolescence
whereas autoimmune thyroid disease affects middle-aged subjects. Within
the category of autoimmune thyroid disease, a variety of differing
pathologies of distinct clinical, histological, HLA and immunological
expression is evident. At first sight, this may be seen as a further
major distinguishing feature between type 1 diabetes and autoimmune thy¬
roid disease since a greater degree of homogeneity appears to be evident
within the type 1 diabetic population.
The aims of the studies embodied in this thesis were
(a) to establish the frequency with which overt and clinically
unrecognised autoimmune thyroid disease are found in the diabetic
population.
(b) to investigate the clinical, metabolic, immunological, fami¬
lial and HLA antigen characteristics of diabetics with coexistent
autoimmune thyroid disease and to compare these characteristics
with those of diabetics without thyroid disease.
(c) to consider possible aetiological factors responsible for the





The distribution of overt autoimmune thyroid disease in the diabetic
population.
In view of the obvious similarities between the pathological
processes culminating in autoimmune thyroid disease and type I diabetes,
the distribution of overt autoimmune thyroid disease in the diabetic
population was investigated. The main purpose of this enquiry was to
compare the prevalence of clinically evident autoimmune thyroid disease
in insulin-dependent (type 1) diabetics with that in non- insulin-
dependent (type 2) diabetics.
Subjects and Methods
The distribution of thyroid disease was established by
(a) interviewing patients and
(b) examining case records of 963 diabetics consecutively attending the
Diabetic and Dietetic Department, Royal Infirmary, Edinburgh. Four
hundred and thirty five patients (196 males, 239 females) were
treated with insulin, 330 (152 males, 178 females) were treated
with oral hypoglycaemic agents (OHA) and 198 (111 males, 87
females) were treated with diet alone.
Where a history of thyroid disease was reported by the patient,
his/her hospital and general practice records were scrutinised. A his¬
tory of thyroid disease was only accepted in those patients in whom
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biochemical proof of hyper- or hypothyroidism had been obtained.
Hyperthyroidism was attributed to autoimmune Graves" disease on the
basis of clinical, histological and/or radioisotope scanning evidence
whereby patients with an overactive nodular goitre were excluded.
Hypothyroidism was always considered to be due to autoimmune thyroiditis
in the absence of contradictory evidence.
2
The data were submitted to x analysis.
Results
Table 1 shows the distribution of autoimmune thyroid disease in the
diabetics studied, according to age, sex and insulin-dependency.
Autoimmune thyroid disease was found in 32 (7.4%) insulin-dependent dia-
betics and 12 (2.3%) non-insulin-dependent diabetics (x = 9.6, p<0.02).
The prevalence of autoimmune thyroid disease was greater in female
(10.9%) than in male (3.1%) insulin-dependent diabetics (x = 40.3,
p<0.01), and greater also in female (3.8%) than male (1.5%) non-
2
insulin-dependent diabetics (x =30.1, p<0.01). Table 2 shows the pre¬
valence of hyper- and hypothyroidism in the diabetics according to dia¬
betic treatment and sex, and includes comparative data obtained by Tun-
bridge et al (1977a) in a non-diabetic control population (n = 2779).
Of the 963 diabetics interviewed 30(3.1%) had Graves' disease and
14(1.4%) had autoimmune primary thyroid failure.
Discussion
A clinical association between thyroid disease and diabetes has
been suspected for many years. However the evidence in favour of such
an association is based upon a small number of anecdotal reports of
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concurrent diabetes and thyroid disease occurring in the same individual
or his family (Hayles et al., 1959; Perlman, 1961; Solomon et al.,
1965; Crome et al., 1967). Where the prevalence of hypothyroidism in
the diabetic population has been studied (Hecht and Gershberg, 1968;
Ganz and Kozak, 1974), no attempt has been made to distinguish between
insulin-dependent and non-insulin-dependent diabetics. As a result, the
strikingly high incidence of hypothyroidism in the insulin- dependent
diabetic population was obscured. Nabarro et al (1979) reported the
incidences of hyper- and hypothyroidism in insulin deficient diabetics
to be 3.0 and 2.4% respectively, and these figures are very similar to
our own of 5.3 and 2.1%. Comparative data from a non-diabetic control
population are provided by a study (Tunbridge et al., 1977a) of the pre¬
valence of overt thyroid disease in a community from the North-East of
England of whom 0.9 and 0.5% had hyper- and hypothyroidism. Thus, it
may be seen that clinically evident hyper- and hypothyroidism are
approximately four times as common in the insulin-dependent diabetic
population as in non-diabetic controls.
In contrast, the distribution of overt autoimmune thyroid disease
is not appreciably greater in the non-insulin-dependent diabetic popula¬
tion than in controls given the fact that the non-insulin-dependent dia¬
betics in the present study were considerably older than the majority of
the controls taken from the Whickham survey. Thus, a clinical associa¬
tion has been demonstrated between autoimmune thyroid disease and
insulin-dependent diabetes, but not non-insulin-dependent diabetes,
which complements those other features common to both insulin-dependent
diabetes and autoimmune thyroid disease as described in Chapter 1.
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Within the population of insulin-dependent diabetics, the risk of
developing co-existing autoimmune thyroid disease might be randomly dis¬
tributed. However, it appears that middle-aged, female, insulin-
dependent diabetics exhibit a particularly high incidence of concomitant
thyroid disease. The significance of this selective association will be
discussed in subsequent chapters of this thesis.
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TABLE 1
Prevalence of overt autoimmune thyroid disease in diabetics
according to age, sex and'Insulin-dependency
Age (yr)
<30 30-39 1+0-U9 50-59 60-69 >69 Total
Insulin-dependent diabetics
Male 0/66 0/3U 0/23 3/1+0 2/21 1/12 6/196
0$ 0$ 0$ 7.5% 9.5$ 8.3$ 3.1$
Female 0/6l 5/31 3/32 5/38 8/39 5/38 26/239





Male 0/5 0/11 0/32 1/69 1/85 0/6l 2/263
0% 0% ' ■ 0$ 1.5$ 1.2$ 0$ 0.8$
Female 0/7 0/3 1/18 1/51 5/98 3/88 10/265
0$ 0$ 5.6% 2$ 5.1$ 3.1+$ 3.8$
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TABLE 2
Comparison of prevalence (%) of overt autoimmune hyperthyroidism























* data derived from Tunbridge et al (1977a),
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CHAPTER 3
A comparison of the prevalences of thyroid antibodies and unrecognised
primary thyroid failure in insulin-dependent and non-insulin-dependent
diabetics.
The prevalence of thyroid cytoplasmic antibodies is greater in
insulin-dependent diabetics than controls (Landing et al., 1963; Irvine
et al., 1970; Whittingham et al., 1971; Neufeld et al., 1980). The
risk is greatest for females and the difference in prevalence between
diabetics and controls is most marked in younger patients (Irvine et
al., 1970; Whittingham et al., 1971). In both insulin-dependent diabet¬
ics and controls, the prevalence of thyroid cytoplasmic antibodies
increases with age. Duration of diabetes and age at onset of diabetes
appear to have no independent influence on the risk of having thyroid
cytoplasmic antibodies (Irvine et al., 1970). However, one report
(Whittingham et al., 1971) suggests a decline in prevalence of thyroid
cytoplasmic antibodies in elderly, insulin-dependent diabetics of long
duration. The same investigators observed vascular disease to be par¬
ticularly common in thyroid antibody positive young diabetics with
long-term insulin dependency and proposed that the decline in prevalence
of thyroid cytoplasmic antibodies in long-standing, elderly insulin-
dependent diabetics was due to selective premature mortality of thyroid
antibody positive insulin-dependent diabetics in middle-age.
The distribution of thyroglobulin antibodies parallels that of thy¬
roid cytoplasmic antibodies with insulin-dependent diabetics exhibiting
a higher prevalence than controls, both groups showing increasing pre¬
valence with age and female insulin-dependent diabetics exhibiting
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particular susceptibility (Irvine et al., 1970; Simkins, 1968). In
contrast to the increased frequency with which thyroid cytoplasmic and
thyroglobulin antibodies are found in insulin-dependent diabetics, nei¬
ther antibody is associated with non-insulin-dependent diabetes (Irvine
et al., 1970; Whittingham et al., 1971). This observation lent early
support to the view (now widely held) that insulin- dependent and non-
insulin-dependent diabetes might have differing pathogeneses. The
appearance of thyroid antibodies was clearly not the result of disor¬
dered carbohydrate metabolism, per se.
The heterogeneous distribution of thyroid antibodies within the
insulin- dependent diabetic population is intriguing and suggests vary¬
ing susceptibility to coincident thyroid autoimmunity based on age and
sex. However, interpretation of cross-sectional prevalence data is han¬
dicapped not only by the distortion introduced by putative selective
factors as proposed by Whittingham et al (1971), but also by the uncer¬
tainty of the relevance of the appearance of thyroid antibodies. Thus,
while it is recognised (Goudie et al., 1959; Bastenie et al., 1967)
that in the control population thyroid antibodies are associated with
thyroiditis in the absence of clinical thyroid disease, they may appear
transiently and be of little functional or pathological significance
(Hawkins et al., 1980; Tunbridge et al., 1981).
In view of the uncertainty of the functional significance of thy¬
roid antibodies and therefore of the relevance of their distribution
within the diabetic population, a study of thyroid function was under¬
taken in a large group of unselected diabetics who had no history of
thyroid disease. The same patients were examined for thyroid antibodies
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and the relationship between antibodies and thyroid function was criti¬
cally evaluated. Particular attention was paid to the comparative pre¬
valence of unrecognised thyroid failure in the insulin-dependent and
non-insulin-dependent diabetic populations.
Subjects and Methods
Three hundred and forty-seven diabetics were studied including 184
insulin- dependent diabetics (91 males, 93 females), 101 patients (44
males, 57 females) treated with OHA and 62 patients (34 males, 28
females) treated by diet alone. The mean ± SE ages of the three groups
of subjects were 49.0 ± 1.0, 53.0 ± 0.9 and 52.0 ± 0.9 years with dura¬
tions of diabetes of 17.4 ± 0.6, 7.3 ± 0.6 and 4.1 ± 0.6 years, respec¬
tively. Of the patients treated with OHA, 38 received a sulphonylurea,
32 a biguanide and 31 a sulphonylurea and biguanide combination. All
patients attended the Diabetic and Dietetic Department, Royal Infirmary,
Edinburgh, and none had previously been suspected of suffering from thy¬
roid disease.
Serum total thyroxine (T4) and TSH concentrations were estimated in
all patients. The sera of 171 insulin-dependent diabetics, 96 patients
treated with OHA and 55 treated with diet alone, including all those
patients with a raised serum TSH, were examined for antibodies to thy¬
roid microsomes and thyroglobulin.
Serum T4 was measured by radio-immunoassay (Seth et al 1974) the
inter-assay co-efficient of variation using anonymous control sera aver¬
aged 11.7%. The reference (normal) range for serum T4 was 60-150nmol/l
for both males and females. Serum TSH was measured by double antibody
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radio-immunoassay using IRP 68/38 as standard (Toft et al., 1978). The
between assay co-efficient of variation was 5.1%. In euthyroid patients
attending an Endocrine Clinic, the 95th percentile of TSH concentration
was 5.7mU/l which was therefore regarded as the upper limit of the
reference (normal) range, with 5% of patients having concentrations
between 5.7 - 10mU/l.
Antibodies to thyroid microsomes were measured by the Fujizoki
tanned cell haemagglutination technique (Amino et al., 1976) in which a
2
titre of 1/160 was considered positive. Antibodies to thyroglobulin
were also measured by a tanned cell haemagglutination technique in which
a titre of 1/25 was regarded as positive.
Statistical analysis was by Student's t test unless otherwise
stated.
Results
An elevated serum TSH concentration was found in 24 insulin-
dependent diabetics, eight diabetics treated with OHA and two treated
with diet alone. The prevalence of a raised serum TSH concentration in
insulin-dependent diabetics (13%) was twice that (6.1%) of non-insulin-
dependent diabetics. The mean ± SE serum TSH concentrations in patients
whose concentrations were elevated and normal were 26.6 ± 7.1mU/l and
2.2 ± l.lmU/1, respectively. Of the 34 patients with an elevated serum
TSH concentration, nine (26.5%) had serum T4 concentrations below the
normal range (mean 44.1 ± 3.7nmol/l). The mean serum T4 concentration
of the remaining patients with a raised serum TSH was 91.0 ± 4.2nmol/l
which was significantly lower (p<0.01) than the level of 104.0 ±
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1.2nmol/l found in patients with normal serum TSH concentrations.
The mean ages at diagnosis of diabetes (37.5 ± 2.8 years) and at
time of study (55.8 ± 2.3 years) of insulin-dependent diabetics with a
raised serum TSH concentration were greater (p<0.02 and <0.01) than the
corresponding ages (30.4 ± 1.1 and 47.8 ± 1.1 years) of insulin-
dependent diabetics with a normal TSH concentration. The duration of
diabetes (17.8 ± 1.6 years) of insulin-dependent diabetics with a raised
serum TSH concentration was similar to that (17.4 ± 0.7 years) of
insulin-dependent diabetics with a normal serum TSH concentration. In
particular, for a given age at diagnosis, or a given age at the time of
study, there was no difference in the duration of diabetes when compar¬
ing insulin-dependent diabetics with a raised and those with a normal
serum TSH concentration. This was investigated by stratifying the
patients according to age in decades and, within each age group, calcu¬
lating the difference in mean duration of diabetes in insulin-dependent
diabetics with normal or elevated serum TSH concentrations, together
with the variance of this difference. The results from all age groups
were then amalgamated into an overall test by forming a weighted mean
difference in duration of diabetes (weights being chosen inversely pro¬
portional to the variances) and calculating the standard error of this
weighted mean. The significance was then determined by referring the
ratio of mean difference to its standard error to tables of the t-
distribution. The stratification procedure was necessary to remove the
effect of the inevitable association between the age of the patient and
the duration of diabetes.
In contrast to the insulin-dependent diabetics, age at time of
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study did not significantly influence the prevalence of a raised TSH
concentration in non-insulin-dependent diabetics. Thus, of 52 such
patients aged less than 50 years, 4 (7%) had an elevated TSH concentra¬
tion, whereas 6 (6%) of 109 patients aged 50 years or more had an
elevated TSH concentration. Within the OHA treated patients, there was
no difference in the frequency with which a raised serum TSH concentra¬
tion was found among patients treated with a sulphonylurea, a biguanide
or a combination of both drugs.
No patient had an elevated serum T4 concentration.
The prevalences of thyroid microsomal and thyroglobulin antibodies
in patients with raised and with normal serum TSH concentrations grouped
according to treatment are shown in Table 3. It was possible to demon¬
strate a significantly higher prevalence of thyroid microsomal antibo¬
dies, but not thyroglobulin antibodies, in insulin-dependent diabetics
and OHA treated diabetics with raised TSH levels than in those with nor-
2
mal TSH concentrations, by means of the x -squared test with Yatesx
correction (p<0.0005 and p<0005, respectively). There was no signifi¬
cant difference in the prevalence of thyroid microsomal antibodies
between insulin-dependent diabetics and OHA treated diabetics with
raised serum TSH concentrations. The number of patients treated with
diet alone who had thyroid antibodies was too small for statistical
analysis.
Discussion
The prevalence of a raised TSH concentration in the non-insulin-
dependent diabetics (6.6%) described in this study is similar to that
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reported in a non-diabetic population (5%) by Tunbridge et al (1977a).
On the other hand, a raised serum TSH concentration is twice as common
in insulin-dependent diabetics (13%) as is found in non-insulin-
dependent diabetics or non-diabetic controls. These findings are in
accordance with the distribution of thyroid antibodies reported in the
diabetic population of whom only insulin-dependent diabetics exhibit a
higher prevalence than controls (Landing et al., 1963; Irvine et al.,
1970; Whittingham et al., 1971; Neufeld et al., 1980). Moreover, the
present study reports a clear association between the presence of thy¬
roid microsomal antibodies and a raised serum TSH concentration in insu¬
lin and OHA treated diabetics. Thyroglobulin antibodies are also more
commonly found in insulin and OHA treated diabetics with raised than
with normal TSH concentrations but the difference fell short of statist¬
ical significance. The association between thyroid failure and thyroid
antibodies suggests that the underlying thyroid pathology is that of
autoimmune thyroiditis. It is of interest that the reported antithyroid
effect of the sulphonylureas (Hunton et al., 1965) was not sufficient to
be manifest as thyroid failure in the present study. Prince et al
(1980) came to the same conclusion having studied thyroid function and
antibody tests in a group of diabetics of differing treatment
categories, of whom only 2 (5%) of 41 patients receiving sulphonylureas
had raised serum TSH concentrations.
In contrast to the apparent association between insulin-dependent
diabetes, thyroid microsomal antibodies and a raised serum TSH concen¬
tration, Feely and Isles (1979) have reported minimal elevation of the
TSH concentration in a large proportion (38%) of non-insulin-dependent
diabetics, most of whom were thyroid antibody negative. The upper limit
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of their normal range for serum TSH concentration was based on values
obtained from control subjects younger than the diabetics under con¬
sideration and the significance of a raised TSH concentration of between
4.5 - 6.0mU/l is questionable. Moreover, patients who had previously
been treated for hyperthyroidism were included in their cross-sectional
survey of thyroid function. Elevation of the serum TSH concentration
following surgical or irradiation treatment of hyperthyroidism is not
uncommon and the inclusion of such patients will inevitably distort the
apparent distribution of primary thyroid failure in the diabetic popula¬
tion.
Clearly only a proportion of insulin-dependent diabetics are sub¬
ject to the development of coincident thyroiditis and thyroid failure,
the risk apparently increasing with increasing age at time of study and
age at time of diagnosis of diabetes. A cross-sectional study, such as
this, is subject to selective mortality of groups of patients such as
has been proposed (Whittingham et al., 1971) for insulin-dependent dia¬
betics with circulating thyro-gastric antibodies. Had this been a major
influence, one would have expected duration of diabetes in patients with
an elevated serum TSH concentration to be shorter than that of euthyroid
diabetics. However, durations of diabetes were identical in both groups
of insulin-dependent diabetics which also indicates that the state of
carbohydrate intolerance cannot, per se, account for the development of
a raised serum TSH concentration.
Although the excessive prevalence of thyroid microsomal antibodies
in diabetics is most evident in young insulin-dependent diabetics
(Irvine et al., 1970; Whittingham et al., 1971) , this group appears
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not to be at immediate risk of developing thyroid failure. Instead, the
older insulin-dependent diabetics are at greatest risk of primary thy¬
roid failure, manifest as a raised serum TSH concentration. It is
tempting to suppose that thyroid failure may only develop after a pro¬
longed period of autoimmune thyroiditis accompanied by circulating thy¬
roid microsomal antibodies. It may be seen (Table 3) that 19% of
insulin-dependent diabetics with a normal serum TSH concentration have
thyroid microsomal antibodies and such patients may be at risk of
developing thyroid failure in future.
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CHAPTER 4
Distribution of unrecognised primary thyroid failure in insulin-
dependent diabetics.
It has been shown in the previous chapter that the risk of a raised
serum TSH concentration parallels that of circulating thyroid antibo¬
dies, being greater in insulin-dependent diabetics than in non-insulin-
dependent diabetics and controls, in whom the risks are not signifi¬
cantly different. Within the population of insulin-dependent diabetics
only a proportion of patients appear to develop autoimmune thyroiditis
but the characterists of those individuals predisposed to coincident
thyroid disease remain ill defined. It was therefore decided to examine
a larger group of insulin-dependent diabetics in order to establish
which patients are most at risk of clinically unrecognised primary thy¬
roid failure in terms of sex, age at diagnosis of diabetes, age at time
of study and duration of diabetes.
Subjects and Methods
Six hundred and five insulin-dependent diabetics (294 males and 311
females) aged 21-84 years, who were attending the Diabetic and Dietetic
Department, Royal Infirmary, Edinburgh, and in whom thyroid disease had
not previously been suspected were studied. Table 4 shows the distribu¬
tion of these patients according to sex, age at time of study and age at
diagnosis of diabetes. Patients were categorized according to whether
they were treated with insulin at or within three months of diagnosis
("primary" insulin-dependent diabetics), or were treated with insulin
more than three months from diagnosis after exhibiting secondary sulpho-
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nylurea failure ("secondary" insulin-dependent diabetics). The serum
TSH concentration was measured in all patients and in those having a
raised TSH level, the serum T4 concentration was also estimated.
The serum T4 and TSH concentrations were measured by previously
described radio-immunoassays (Seth et al., 1976; Toft et al., 1978).
The statistical analyses were carried out by fitting a linear
logistic or log linear model to the data using the GLIM computer pack¬
age, unless otherwise indicated.
Results
Seventy-one (11.7%) of the insulin-dependent diabetics studied had
elevated serum TSH concentrations and 15 (21%) of these had serum T4
concentrations below the normal range. Figure 1 shows the distribution
of serum T4 and TSH concentrations in the patients with primary thyroid
failure.
Figure 2 shows the prevalence of an elevated serum TSH concentra¬
tion in male and female insulin-dependent diabetics according to age at
diagnosis of diabetes and age at the time of study. The prevalence of a
raised serum TSH concentration in females of all ages (17.0%) was signi¬
ficantly greater (p<0.0005) than that in males (6.1%). The prevalence
of a raised serum TSH concentration increased with increasing age at
onset of diabetes (p<0.05) and age at time of the study (p<0.001) in
females but not in males. Thus, of 156 females aged 50 years or more at
the time of the study, 38 (24.4%) had elevated serum TSH concentrations,
and 8 (5.1%) of these had low serum T4 concentrations. Of 138 males
aged 50 years or more at the time of the study, 11 (8%) had elevated
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serum TSH concentrations and 4 (2.9%) had low serum T4 concentrations.
The duration of diabetes of 17.7 ±1.3 years in insulin-dependent
diabetics with raised serum TSH concentrations is not significantly dif¬
ferent (Students t test) from that of 15.5 ± 0.4 years in insulin-
dependent diabetics with normal serum TSH concentrations. There was no
difference in the duration of diabetes for any given age at diagnosis of
diabetes or any given age at time of study when comparing insulin-
dependent diabetics with raised and with normal serum TSH concentra¬
tions. Similarly, no difference was observed when male and female
insulin-dependent diabetics were considered independently.
In females aged 40 years or more at the time of study, it was not
possible to establish a statistically significant difference between the
prevalence of a raised serum TSH concentration in "primary" insulin-
dependent diabetics (20%) and that in "secondary" insulin-dependent dia¬
betics (23.4%). Similarly, in males aged 40 years or more at the time
of study, the prevalence of a raised serum TSH concentration was not
significantly higher in "primary" insulin-dependent diabetics (8.4%)
than in "secondary" insulin-dependent diabetics (5.7%).
Discussion
This study confirms the risk of unrecognised or subclinical thyroid
failure in insulin-dependent diabetics to be approximately twice that
found in non- insulin-dependent diabetics and non-diabetic controls. In
addition, it appears that the increased risk is found mainly in women of
whom almost one in five has an elevated serum TSH concentration.
Nevertheless, the prevalence of subclinical thyroid failure in male
- 42 -
insulin-dependent diabetics is also twice that reported in male non-
diabetics (Tunbridge et al., 1977a). The particular susceptibility of
the older, female insulin-dependent diabetics to primary thyroid failure
accords with the reported distribution of thyroid microsomal antibodies
in the diabetic population (Irvine et al., 1970; Whittingham et al.,
1971). Female proponderance is also recognised in other autoimmune
diseases appearing in middle age such as pernicious anaemia, Addisonvs
disease, primary atrophic hypothyroidism, Gravesvdisease and Hashimotovs
thyroiditis.
In female insulin-dependent diabetics, the frequency with which a
raised serum TSH concentration is found increases with increasing age at
onset of diabetes and with increasing age at time of study, which are
inter-dependent. If increasing age at diagnosis of diabetes was the
main influence on the risk of developing primary thyroid failure, then
insulin-dependent diabetics with raised serum TSH concentrations would
have been diabetic for less time for any given age at the time of study,
than insulin-dependent diabetics with normal serum TSH concentrations.
If senescence alone increased the risk of developing primary thyroid
failure, then insulin-dependent diabetics with raised serum TSH concen¬
trations would have been diabetic longer for any given age at diagnosis
of diabetes than diabetics with normal serum TSH concentrations. How¬
ever, it was found that the duration of diabetes was similar in diabet¬
ics with raised and normal serum TSH concentrations and therefore, it
was not possible to determine whether age at diagnosis of diabetes or
age at time of study was the predominant influence on the probability of
finding a raised serum TSH concentration. It has been shown (Chapter 6)
that there is a correlation between age at onset of diabetes and that of
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thyroid failure, such that age at study and age at onset of diabetes may
equally determine the risk of developing thyroid failure.
Little attempt has yet been made to compare late-onset "primary"
and "secondary" insulin-dependent diabetics. Although they are both
regarded as type 1 diabetics, having the same aetiology as the more typ¬
ical juvenile onset insulin-dependent diabetics, confirmation in terms
of immunological and genetic studies is lacking. The present study
shows no difference in the prevalence of associated thyroid failure
between late-onset "primary" and "secondary" insulin-dependent diabet¬
ics, and to this extent the two groups are similar. It seems likely,
however, that the two groups differ in the rate of deterioration of car¬
bohydrate tolerance, since some "secondary" insulin-dependent diabetics
remain insulin independent for many years after the diagnosis of dia¬
betes.
Conclusion
These studies show that unrecognised primary thyroid failure is
extremely common in the insulin-dependent diabetic population, and is
associated with circulating thyroid microsomal antibodies indicative of
underlying autoimmune thyroiditis. The risk is greatest in females,
increases with increasing age, and is similar in patients requiring
insulin treatment from the outset and those exhibiting secondary sulpho-
nylurea failure. It may be seen that the same diabetic patients are
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Prevalence of an elevated TSH concentration in insulin-
dependent diabetics according to sex, age at diagnosis
of diabetes, and age at time of study.
TABLEk Sexandgeof605insulin-dependentdiab ticsiagno isofdiabetesa dttimeftudy 0-10-
Atdiagnosis Females Males Attimeofstudy Females Males
21(0)55(0) 12(0)52(0)






61(10)37(57)+ (56)20(60)6 67) 60(17)52(1+0)5(6 )ll (100) 1+5(2)56(11+)67( +8)1+1( 1)1+0(1+0) 53(6)58(12)65 26)5l+(33)19(58)
80- 8(50)
4^
Thepercentageof"secondary"i suli -dependentdi bet ssshownpar thesis
- 47 -
CHAPTER 5
Natural history of thyroid function in diabetics with impaired thyroid
reserve, including an examination of the lipid profiles of diabetics
with primary thyroid failure and their response to thyroxine treatment.
The prevalence of impaired thyroid reserve, as evidenced by a
raised serum TSH concentration but serum T4 concentration within the
normal range, is increased in insulin-dependent diabetics with older
female patients being particularly at risk. Although it seems likely
that thyroid failure develops only after prolonged thyroiditis, the
natural history of thyroid function in such diabetics has not yet been
studied. Cross-sectional studies suffer from the possible selective
mortality of groups of subjects such as those with thyroid antibodies
(Whittingham et al., 1971). Studies of the natural history of autoim¬
mune thyroiditis in non-diabetics are not uniform (Gordin and Lamberg,
1981; Tunbridge et al., 1981) and may bear little relation to the
natural history of this condition in the diabetic population. There¬
fore, a group of diabetics with impaired thyroid reserve has been stu¬
died prospectively and the natural history of thyroid function in these
patients has been compared with that of a group of diabetics having nor¬
mal thyroid function. Mortality in these two groups of patients has
also been compared with that of diabetics found to be hypothyroid and
treated with thyroxine.
Patients and Methods
Patients comprised those described in previous cross-sectional stu¬
dies of the prevalence of unrecognised thyroid failure in the diabetic
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population, carried out between 1973-1979 (Chapters 3 and 4). Eighty
patients had elevated serum TSH concentrations (median 8.9mU/l, range
5.8-46.3mU/l) but serum T4 concentrations (median 82.0nmol/l, range 60-
136nmol/l) within the normal range (Group 1). Thyroid function and
antibody status of these patients were reviewed, where possible, at reg¬
ular intervals (1-3 years) until 1981. Patients were only treated with
thyroxine when found to have subnormal T4 and elevated TSH concentra¬
tions in the serum. Fifty nine patients in Group 1 completed review and
were individually matched restrospectively for age, sex, duration of
diabetes and diabetic treatment with diabetics having had normal serum
T4 and TSH concentrations during the original cross-sectional studies
(Group 2). A single review of thyroid function and antibody status was
attempted for each control subject of Group 2 in 1981. Group 3 included
24 patients found between 1973-1979 to have subnormal serum T4 concen¬
trations (median 42nmol/l, range 25-59nmol/l) and elevated serum TSH
concentrations (median 37mU/l, range 10-239mU/l), who were thereafter
treated with thyroxine in a dose of 0.1 - 0.25mgs daily, sufficient to
maintain the serum TSH concentration within the normal range and the
patient clinically euthyroid.
Table 5 shows the sex, age, duration of diabetes and treatment of
patients in the three groups when first recruited.
The serum T4 and TSH concentrations were measured by previously
described radio-immunoassays (Seth et al., 1976; Toft et al., 1978).
Antibodies to thyroid microsomal antigen were measured by the
indirect immuno-fluorescence technique using undiluted serum. Antibo¬
dies to thyroglobulin were detected by means of the tanned cell
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haemagglutination technique, taking a titre of > 25 as significant.
Results are expressed as median and range or mean ± standard error (SE),
2
where appropriate. Statistics were carried out by means of x analysis
and Student's t test.
Results
The mean periods of follow-up from recruitment until 1981 were
similar for patients in Group 1 (4.2 ± 0.2 years), Group 2 (4.2 ± 0.2
years) and Group 3 (4.0 ± 0.3 years). Table 6 shows the numbers of
patients in each group who successfully completed follow-up and those
who were lost to follow-up or died. Similar proportions of patients in
the three groups were lost to follow-up or successfully completed full
review. Although fewer patients in Group 2 died (12%) than those in
Group 1 (20%) and Group 3 (25%) these differences were not statistically
significant.
Thyroid Function
Fifty-nine patients in Group 1 successfully completed follow-up
until 1981, each having been reviewed 1-5 times, the majority (85%) hav¬
ing been reviewed twice or more over a period of 2-8 years. The natural
history of thyroid function in these patients exhibited four different
patterns:
(a) All subsequent serum TSH and T4 concentrations falling within the
normal range (n = 7)
(b) Intermittent elevation of the serum TSH concentration with serum T4
concentrations remaining within the normal range (n = 14)
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(c) Persistent elevation of the serum TSH concentration with serum T4
concentrations remaining within the normal range (n = 29)
(d) Persistent elevation of the serum TSH concentration with serum T4
concentrations falling below the normal range (n = 9)
Table 7 shows the median serum TSH and T4 concentrations at the
time of recruitment and in 1981 (or when first found to have subnormal
serum T4 concentrations) of the Group 1 patients according to their
natural history of thyroid function. It may be seen that of the 59
patients followed for approximately 4 years, 9 (3.6% per annum) became
hypothyroid and were treated accordingly. The majority (86%) of the
remaining patients continued to exhibit impaired thyroid reserve without
significant change in thyroid function, including 14 patients (Group lb)
who showed intermittent elevation of serum TSH concentration, whose
sequential serum TSH and T4 concentrations are shown in Table 8. The
minority (Group la; 14%) regained normal thyroid function. It was not
possible to predict the natural history of thyroid function in indivi¬
dual patients on the basis of their initial serum T4 and TSH concentra¬
tions .
At the time of recruitment, median serum T4 and TSH concentrations
in patients of Group 2 were 99nmol/l (range 68-148nmol/l) and 1.9mU/l
(range 0.8 - 4.7mU/l) and had not significantly changed in 47 patients
retested in 1981 (94nmol/l, range 60-132nmol/l and 1.9mU/l, range 1.0 -
6.2mU/l). Included within the 47 patients who were reviewed in 1981
were two female patients with minimally elevated TSH concentrations (6.1
and 6.2 mU/1) but normal serum T4 concentrations (84 and 80 nmol/1).
The remaining 45 patients had normal thyroid function.
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Thyroid Antibody Status.
At recruitment, 52 (65%) patients of Group 1 and 9(15%) of Group 2
had positive thyroid microsomal antibodies (p < 0.01), whereas at the
same stage 14 (18%) of Group 1 and 1 (2%) of Group 2 had positive thyro-
globulin antibodies. Table 7 shows the thyroid antibody status of
patients in Group 1 who completed follow-up in relation to natural his¬
tory of thyroid function. Positive thyroid microsomal antibodies tended
to be associated with development of hypothyroidism and patients who
subsequently exhibited normal thyroid function were commonly negative
for thyroid microsomal antibodies. However, there was no significant
difference between the Group 1 patients showing the four different types
of natural history in respect of prevalence of thyroid microsomal anti¬
body at recruitment. Similarly, although the proportion (20.5%) of thy¬
roid microsomal antibody positive Group 1 diabetics (n 39) who developed
hypothyroidism was greater than that (5%) of antibody negative Group 1
diabetics (n 20), this difference was not statistically significant.
At follow-up, 4 (7%) patients in Group 2 had thyroid microsomal
antibodies and 3 (6%) had thyroglobulin antibodies. Of the two patients
in Group 2 who developed an elevated serum TSH concentration, 1 had
positive thyroid microsomal antibodies at recruitment and at follow-up,
and positive thyroglobulin antibodies at follow-up only. The other
patient remained thyroid antibody negative.
Table 9 compares the thyroid microsomal antibody status at recruit¬
ment and at follow-up, in 1981, of patients in Group 1 and 2. Similar
proportions of patients in Group 1 (85%) and Group 2 (82%) maintained
their antibody status during the study. However, the majority (78%) of
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patients in Group 2 who were initially antibody positive subsequently
became antibody negative.
DISCUSSION
Although insulin-dependent diabetics are susceptible to impaired
thyroid reserve it cannot be assumed that all such affected patients
invariably develop frank hypothyroidism. This study shows that only a
proportion of diabetics with impaired thyroid reserve demonstrate pro¬
gressive thyroid failure to hypothyroidism. Those with elevated serum
TSH concentrations accompanying thyroid microsomal antibodies are at
greatest risk of developing hypothyroidism (5% per annum), whereas,
patients with elevated serum TSH concentration without thyroid micro¬
somal antibodies rarely develop hypothyroidism (1% per annum). A simi¬
lar experience was reported by Tunbridge et al. (1981) who observed
hypothyroidism to develop at a rate of 5% per annum in non-diabetics
with elevated TSH concentrations and positive thyroid microsomal antibo¬
dies. Thus, the coincidence of diabetes has no bearing on the natural
history of autoimmune thyroiditis. A higher incidence of hypothyroidism
(26% per annum) is reported (Gordin and Lamberg, 1981) in non-diabetic
patients with symptomless autoimmune thyroiditis who had substantially
higher initial TSH concentrations, as might be predicted.
The presence of thyroid microsomal antibodies without elevation of
the serum TSH concentration appears to have little predictive value,
such patients commonly losing the antibody at review. Transient appear¬
ance of thyroid antibodies (Hawkins et al., 1980; Tunbridge et al.,
1981) may be associated with intercurrent viral illnesses which probably
have little bearing on long-term thyroid function. Nevertheless it has
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been suggested (Riley et al., 1981) that positive thyroid microsomal
antibodies alone are sufficient grounds for annual review of thyroid
function. In our experience, this is not necessary since thyroid func¬
tion deteriorates very slowly, if at all, in such patients, many of whom
exhibit thyroid microsomal antibodies transiently. Similarly, Gordin
and Lamberg (1981) report that of ten non-diabetic patients with symp¬
tomless autoimmune thyroiditis, but normal serum TSH concentrations, who
were followed approximately five years, none developed hypothyroidism.
Although patients at greatest risk of developing hypothyroidism are
those with thyroid microsomal antibodies and elevated serum TSH concen¬
trations, not all such patients demonstrate progressive thyroid failure
and it was not possible to predict the outcome in individual patients
using the indices of this study. A variable degree of thyroid underac¬
tivity, as evidenced by intermittent elevation of serum TSH concentra¬
tions, is exhibited by a substantial proportion of patients which
further complicates any attempt to predict future thyroid dysfunction.
Transient elevation of serum TSH concentration has been noted in non-
diabetics, but may be yet more common in diabetics where metabolic con¬
trol may influence the prevailing serum TSH concentration (Alexander et
al., 1982).
In contrast to the general agreement regarding which subjects with
impaired thyroid reserve are at greatest risk of developing hypothy¬
roidism, there is widespread uncertainty as regards their appropriate
management. Although the mortality of diabetics with impaired thyroid
reserve is approximately twice that of euthyroid diabetics, the differ¬
ence was not significant. A significant difference might have helped to
explain the disproportionate cardiovascular mortality of middle-aged
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female insulin-dependent diabetics (Garcia et al., 1974; Gordon et al.,
1977) - the group we have shown to be most at risk of sub-clinical thy¬
roid failure. It is possible that treatment with thyroxine supplements
of all patients with elevated TSH concentrations and thyroid microsomal
antibodies might improve their survival and although this policy has
been advocated (Tunbridge et al., 1981), it remains of no proven value.
Thyroxine treatment of a small group of hypothyroid patients failed to
appreciably improve their mortality which remained similar to that of
diabetics with impaired thyroid reserve. It could be be argued that
significant atherosclerosis had developed prior to institution of thy¬
roxine treatment and that such treatment under these circumstances might
only precipitate myocardial infarction. Whether or not diabetics with
impaired thyroid reserve are treated with thyroxine, they will require
regular review of thyroid function, with dose adjustment or initiation
of thyroxine therapy, accordingly.
Plasma lipids in diabetics with primary thyroid failure
We have shown that the mortality of diabetics with untreated
impaired thyroid reserve or those who have been treated with thyroxine
for hypo thyroidism, is approximately twice that of euthyroid diabetics.
The difference in mortality was not significant, possibly due to the
relatively small number of patients under review. Indirect support for
the hypothesis that diabetics with thyroiditis are at particular risk of
premature cardiovascular desease has previously been provided by the
cross-sectional study of Whittingham et al (1971). Similarly, non-
diabetics with symptomless autoimmune thyroiditis have been described
(Bastenie et al., 1971; 1977; Tunbridge et al., 1977b) to be at
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increased risk of cardiovascular disease. One potential consequence of
primary thyroid failure, known to be a risk factor for cardiovascular
disease in the diabetic population (Lowy and Barach, 1958), is hyper-
cholesterolaemia. While hypercholesterolaemia is recognised to be a
feature of hypothyroidism (Peters and Man, 1950; O'Hara et al., 1966),
the lipid profile of patients with impaired thyroid reserve is contr¬
oversial (Bastenie et al., 1971; 1977; Tunbridge et al., 1977b). The
lipid profile of diabetics with primary thyroid failure has not yet been
examined and is the subject of this study.
Patients and Methods.
Forty-nine patients (Group 1: 11 males, 38 females) with raised
serum TSH concentrations and 49 patients (Group 2: 12 males, 37 females)
with normal serum TSH and T4 concentrations were studied. The mean age,
duration of diabetes and per cent ideal body weight of patients in Group
1 were 55.5 ± 1.6 years, 16.4 ± 1.2 years and 100.6 ± 1.8% and of
patients in Group 2 were 59.3 ± 1.5 years, 16.8 ± 1.2 years and 95.2 ±
1.6% ideal body weight. Forty-two patients in Group 1 and 44 patients
in Group 2 were insulin treated, the remaining patients receiving a car¬
bohydrate restricted diet with or without OHA therapy. For the purpose
of further analysis, patients in Group 1 were divided into those having
subnormal serum T4 concentrations (Group la, n 22) and those whose serum
T4 concentrations were within the normal range (Group lb, n 27). None
received drugs known to alter plasma lipids and diabetic control was
satisfactory in each patient, who was free of ketonuria on the morning
of the study. Three patients in Group 1 and five in Group 2 had
elevated serum creatinine concentrations (150-200 umol/1) although none
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was nephrotic.
Fasting venous blood samples were obtained and analysed for
cholesterol, triglycerides and lipoproteins together with TSH and T4.
Plasma cholesterol and triglyceride estimations were carried out on
a Technicon SMAC (Technicon Instruments Company, Basingstoke, England)
using standard methodology and reagents provided for this instrument by
the manufacturers. Between-batch precision was 2.5% coefficient of
variation for cholesterol and 5% coefficient of variation for tri¬
glyceride. In our laboratory, the normal range for adults for plasma
cholesterol is 3.6 - 6.7mmol/l and for plasma triglyceride is 0.6 - 1.7
mmol/1. Lipoprotein electrophoresis was carried out on agarose (Corning
ACI, Palo Alto, USA), and the stained strips were assessed visually.
Statistical analysis was carried out by Studentvs t test and
Wilcoxon^s test for paired differences.
Results
Table 10 compares plasma lipids and mean T4 and TSH concentrations
of patients in Groups 1 and 2. The mean plasma cholesterol concentra¬
tion is higher in patients of Group la (p < 0.005) and higher in all
patients of Group 1 (p < 0.05) than in patients of Group 2. There was
no significant difference in the mean cholesterol concentration of
patients in Group lb and that of patients in Group 2. Patients of
Groups 1 and 2 had similar triglyceride concentrations.
A significant relationship was observed between plasma cholesterol
and serum TSH concentration (r = 0.56, p < 0.01) and serum T4 concentra-
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tions (r = -0.51, p < 0.05) in respect of patients in Group la, but not
in patients of Group lb nor patients in Group 2.
In 18 patients of Group la, six weeks thyroxine replacement therapy
(0.1 - 0.2 mg daily) led to a significant reduction (p < 0.01) in mean
plasma cholesterol concentration to 5.8 ± 0.3 mmol/1 and a non¬
significant reduction in mean triglyceride concentration to 1.33 ± 0.2
mmol/1 while returning thyroid function to normal (TSH 2.74 ± 0.4 mU/1,
T4 96.7 ± 5.2 nmol/1). Four of seven patients with Type 2 hyperlipopro¬
teinemia regained a normal lipoprotein electrophoretic pattern.
Discussion
This study shows that clinically unrecognised primary thyroid
failure in diabetics is associated with a modest, yet significant,
elevation of the plasma cholesterol concentration. The elevation is
only significant in hypothyroid diabetics who show a correlation between
degree of thyroid underactivity and degree of hypercholesterolaemia, and
in whom hypercholesterolaemia is reversed by thyroxine treatment. Dia¬
betics with elevated serum TSH concentrations but serum T4 concentra¬
tions within the normal range are not hypercholesterolaemic. These
findings are in accordance with those reported in non-diabetics with
primary thyroid failure of whom only the hypothyroid subjects demon¬
strate hypercholesterolaemia (Bastenie et al., 1971; Tunbridge et al.,
1977b; Kutty et al., 1978). Reports of hypercholesterolaemia in the
presence of an exaggerated TRH response or minimal elevation of basal
TSH concentration only (Alaghband-Zadeh et al., 1977), have not been
confirmed and thyroxine treatment of such patients does not alter the
plasma cholesterol concentration (Nilsson et al., 1976).
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If macrovascular disease is a feature of diabetics having impaired
thyroid reserve and autoimmune thyroiditis, the macroangiopathy cannot
be attributed to hypercholesterolaemia. It remains possible that circu¬
lating thyrogastric antibodies may be atherogenic as suggested by
Mathews et al.(1974).
TABLE5 Clinicalcharacteristicsofstudygro psrec ui ment Durationof GroupSexAge(yr)diabet sInsulin
(yr)
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Outcome of study groups after four year follow-up
Group
•
Completed follow-up Lost to follow-up Died
1 n=80 59 (lh%) 5(6%) 16(20$)
2 n=59 U7(80$) 6(10%) 7(12$)
3 n=2b 16(67$) 2(8%) 6(25$)
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Thyroid function in diabetics with intermittent elevation of
serum TSH concentration
Year of follow--up
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The clinical features of diabetics with coexisting autoimmune thyroid
disease.
It has been shown earlier in the thesis (Chapters 2, 3 and 4) that
clinically evident autoimmune hyper- and hypothyroidism together with
clinically unrecognised primary thyroid failure are found more fre¬
quently in the insulin-dependent diabetic population than in controls
and non-insulin-dependent diabetics. A study of a large group of dia¬
betics with coexisting, clinically evident autoimmune thyroid disease
whose clinical characteristics may be compared and contrasted with sub¬
jects having diabetes or thyroid disease alone was undertaken.
Patients and Methods
Two hundred and fifteen diabetics with associated overt thyroid
disease were studied who had been randomly selected from patients
attending the Diabetic and Dietetic Department, Royal Infirmary, Edin¬
burgh. Although they represented every recognised case of coexisting
autoimmune thyroid disease and diabetes, the possibility remains that a
number of such patients within the clinic population failed to be iden¬
tified and were therefore inadvertently omitted. Where hypothyroidism
followed treatment of hyperthyroidism, the patient was classified in the
hyperthyroid group only. The clinical diagnoses of hyperthyroidism and
primary hypothyroidism were confirmed by currently available tests of
thyroid function, including estimation of plasma protein - bound iodine,
effective thyroxine ratio, T4 and TSH concentrations and by means of the
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TSH stimulation test. Hyperthyroidism was shown to be due to Graves*
disease on the basis of clinical, histological and/or radio-isotope
scanning evidence whereby patients with an overactive nodular goitre or
other cause of non-Graves* hyperthyroidism were excluded. In the popu¬
lation of diabetics under consideration, the aetiology of primary
hypothyroidism may be assumed to be autoimmune thyroiditis in the major¬
ity of cases, two-thirds of whom have circulating thyroid auto¬
antibodies (Chapter 8).
Table 11 shows the mean age at diagnosis of diabetes in hyperthy-
roid and hypothyroid diabetics in relation to diabetic treatment. A
distinction was again made between "primary" and "secondary" insulin-
dependent diabetics. The statistical analysis was carried out using
regression techniques employing the GLIM computer package.
Results
Figure 3 shows the age at diagnosis of diabetes, hyperthyroidism
and hypothyroidism in the patients studied, in relation to their sex
distribution. The mean ages at diagnosis of diabetes and thyroid dys¬
function in hyperthyroid diabetics (46 ± 2 and 42 ± 1 years) were
younger (p < 0.001 and p < 0.001) than those of hypothyroid diabetics
(52 ± 2 and 58 ± 1 years). There were no significant differences
between the sexes in respect of age at diagnosis of these conditions.
Seventy-six (65%) hyperthyroid and 50 (51%) hypothyroid diabetics
required insulin treatment. Twenty-eight (68%) hyperthyroid and 24
(50%) hypothyroid non-insulin-dependent diabetics were treated with a
sulphonylurea, the remaining non-insulin-dependent diabetics being
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treated by diet with or without a biguanide. Table 11 shows that within
the diabetic treatment groups of hyperthyroid and hypothyroid diabetics,
the "primary" insulin-dependent diabetics were diagnosed as diabetic at
a younger age than the "secondary" insulin-dependent diabetics combined
with non-insulin-dependent diabetics (p < 0.001 and p < 0.001, respec¬
tively). The median age at diagnosis of diabetes in hyperthyroid and
hypothyroid "primary" insulin-dependent diabetics was 36 years.
Within the group of hypothyroid, but not hyperthyroid diabetics,
the "secondary" insulin-dependent diabetics were diagnosed as diabetic
at a younger age (p < 0.01) than the non-insulin-dependent diabetics.
In both the hyperthyroid and hypothyroid "secondary" insulin-dependent
diabetics, the mean interval between diagnosis of diabetes and subse¬
quent insulin treatment was 3 ± 3 years. The median durations of dia¬
betes in hyperthyroid and hypothyroid non-insulin-dependent diabetics
were seven years (range 1-25 years) and five years (range 1-18
years) .
Information regarding the presence of ketonuria at diagnosis of
diabetes was available in 82 hyperthyroid and 69 hypothyroid diabetics.
Twenty-eight (34%) hyperthyroid and 22 (32%) hypothyroid diabetics exhi¬
bited ketonuria at diagnosis. When hyperthyroid and hypothyroid diabet¬
ics were considered together, there was a significant inverse correla¬
tion (p < 0.001) between the incidence of ketonuria and age at diagnosis
of diabetes.
A striking correlation was observed between age at diagnosis of
diabetes and thyroid dysfunction in hyperthyroid (r = 0.71, p < 0.001)
and hypothyroid (r = 0.65, p < 0.001) diabetics. Similar correlations
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were found when "primary" insulin-dependent diabetics (r = 0.62, p <
0.001; r = 0.59, p < 0.001), "secondary" insulin-dependent diabetics (r
= 0.42, p<0.02; r = 0.77, p< 0.001) and non-insulin-dependent dia¬
betics (r = 0.72, p < 0.001; r = 0.70, p < 0.001) were considered
independently. A similar correlation (r = 0.81, p < 0.001) was exhi¬
bited by hypothyroid non-insulin-dependent diabetics treated by diet
with or without a biguanide. For hyperthyroid and hypothyroid diabet¬
ics, the regression lines for the three diabetic treatment categories
did not differ significantly in slope, when age at onset of diabetes is
compared with age at onset of thyroid disease.
Table 12 shows that with increasing age at diagnosis of diabetes
the interval between diagnosis of diabetes and that of hyperthyroidism
or hypothyroidism fell (p < 0.001 and p < 0.001). This interval was
significantly longer (p < 0.001) in hypothyroid diabetics (6.7 ± 1.2
years) than in hyperthyroid diabetics (-2.4 ±1.2 years)
Discussion
The Diabetic Department of the Royal Infirmary, Edinburgh, provides
care for almost 90% of the local diabetic population (Falconer et al.,
1971) whose female to male ratio is 1.3 : 1. A third of our general
diabetic population is insulin treated, the majority of "primary"
insulin-dependent diabetics being diagnosed before the age of 25 years,
as reported elsewhere (Gamble and Taylor, 1969; Gamble, 1980a). In
contrast, we now show that diabetics with associated autoimmune thyroid
disease exhibit marked female preponderance with a female to male ratio
6.4 : 1. The proportion of insulin-dependent to non-insulin-dependent
diabetics (1.4 : 1) is almost three times greater than that observed in
- 69 -
our general diabetic population (1 : 2). Moreover, the median age at
diagnosis of diabetes in "primary" insulin- dependent diabetics with
associated autoimmune thyroid disease is 36 years, that is, appreciably
older than in the general diabetic population. Thus, diabetics with
associated autoimmune thyroid disease display a number of clinical
features at variance with the general diabetic population. On the other
hand, both groups of diabetics exhibit an inverse relationship between
age at onset and severity of diabetes at presentation. A similar rela¬
tionship has previously been described (Gharib and Gastineau, 1969) in
diabetics with associated Addisonxs disease suggesting that the putative
autoimmune process responsible for beta cell destruction becomes less
aggressive with increasing age. Conflicting reports regarding the pre¬
valence of insulin-dependency in diabetics with associated autoimmune
thyroid disease may be reconciled on consideration of the age at diag¬
nosis of diabetes. Bottazzo et al (1978) selected patients on the basis
of insulin-dependence, whose mean age at diagnosis of diabetes was 36
years. Other studies (Ganz and Kozak, 1974; Sugrue et al., 1980) which
have included late-onset diabetics, report a prevalence of insulin-
dependency to be 43 and 83% respectively. Our own findings clearly
indicate that insulin-dependency becomes less prevalent with advancing
age at diagnosis of diabetes in those patients having coexisting autoim¬
mune thyroid disease.
The increased representation of female patients among diabetics
with associated autoimmune thyroid disease is intriguing and remains
unexplained. It has been demonstrated that the risk of development of
diabetes in mice infected with encephalomyocarditis virus is increased
by pre-treatment with testosterone (Boucher et al., 1975; Craighead and
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Higgins, 1974; Morrow and Craighead, 1980) and male mice are particu¬
larly susceptible to the diabetogenic effects of streptozotocin.
(Bonnevie-Nielson et al., 1981) Similarly, the diabetogenic effects of
N-nitroso compounds appear to be most marked in male subjects (Helgason
and Jonasson, 1981), and the seasonal incidence of diabetes is most
apparent when considering male juvenile-onset, insulin-dependent diabet¬
ics. Thus, environmentally induced diabetes may be associated with the
male gender. In contrast, a pure autoimmune aetiology of diabetes may
be associated with the female gender. It should, however, be noted that
the incidence of diabetes in animal models of autoimmune insulitis is
not sex-related and this model is probably the best representation of
pure autoimmune diabetes.
It is of interest that the sex ratio and age at diagnosis of
autoimmune hyperthyroidism and hypothyroidism are very similar in the
diabetic population, reported in this study, and non-diabetic popula¬
tion, reported by others (Tunbridge et al., 1977a; Sugrue et al.,
1980).
The highly significant correlation between age at diagnosis of dia¬
betes and of thyroid disease is similar to that described in respect of
idiopathic Addison*s disease and autoimmune ovarian failure (Irvine and
Barnes, 1975). These observations support the view that where two
autoimmune diseases are found to accompany one another in the same
patient, both conditions are caused by a common and coincident patho¬
genesis. In the present study, we have shown that the correlation
between age at diagnosis of diabetes and of thyroid disease is also
found in non-insulin- dependent diabetics who may share the same aetiol-
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ogy. The correlation extends to diet/biguanide treated hypothyroid
non-insulin- dependent diabetics and cannot, therefore, be attributed to
the anti-thyroid effect of the sulphonylureas (Hunton et al., 1965).
It must be said that although a strong relationship appears to link
the timing of onset of diabetes and of thyroid disease, this relation¬
ship may not necessarily be due to a coincident pathogenesis, but merely
to a coincidence of two life events. Alternatively, it seems possible
that the pathological processes responsible for the development of dia¬
betes and thyroid disease in the same patient are initiated simultane¬
ously. The appearance of thyroid and gastric parietal cell antibodies
appears to coincide with the onset of clinical type 1 diabetes (Riley et
al., 1983) and animal models of type 1 diabetes develop thyroiditis and
diabetes coincidentally (Sternthal et al., 1981).
In man, the order in which diabetes and hyperthyroidism or hypothy¬
roidism become clinically evident appears to be related to the age at
diagnosis of diabetes. Thus, whilst diabetes precedes thyroid disease
in juvenile-onset diabetics, the order is reversed in late-onset diabet¬
ics. This observation may be explained by the rapid deterioration of
carbohydrate tolerance in juvenile-onset diabetics leading to the early
clinical diagnosis of diabetes and insulin-dependency. Late-onset dia¬
betics run a more benign course and thus may have subclinical diabetes
for seveal years prior to its diagnosis. Similarly, the extended
natural history of asymptomatic autoimmune thyroiditis (Chapter 5) may
explain why the diagnosis of hyperthyroidism precedes that of hypothy¬
roidism irrespective of the age at diagnosis of diabetes.
In conclusion, the evidence derived from histological,
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immunological, HLA and family studies (Chapter 10), indicate that type 1
diabetes and autoimmune thyroid disease are caused by a similar patho¬
genesis. The present study supports this premise and suggests that the
pathological processes responsible for the development of diabetes and
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CHAPTER 7
Comparison of retinopathy in insulin-dependent diabetics with and
without coexisting autoimmune thyroid disease.
The risk of developing diabetic microangiopathy is not uniformally
distributed within the insulin-dependent diabetic population. A small
proportion of patients seem to be subject to the early development of
florid proliferative retinopathy, while other patients fail to develop
significant retinopathy despite having been diabetic for forty years or
more (Oakley et al., 1974). The factors governing the respective risks
of the development of retinopathy in these two populations remain ill-
defined. It was therefore of considerable interest when a group of
workers suggested (Bottazzo et al., 1978b) that diabetics with auto¬
immune thyroid disease might be at particular risk of the development of
retinopathy. Indirect support for this view was provided by the
reported association between circulating immune complexes, commonly
found in patients with autoimmune thyroid disease (Calder et al., 1974),
and microangiopathy (Di Mario et al., 1980). We therefore compared the
prevalence and severity of retinopathy in insulin- dependent diabetics
with and without autoimmune thyroid disease to establish whether such
patients are at particular risk of developing retinopathy. Since dura¬
tion of diabetes has a major influence on the prevalence of retinopathy,
we chose to ignore non-insulin-dependent diabetics in whom the duration
of diabetes is difficult to assess.
Patients and Methods
The patients were divided into two groups according to the presence
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or absence of coincident autoimmune thyroid disease. Group 1 included
60 insulin-dependent diabetics (9 males, 51 females) with Graves'
disease and 105 insulin-dependent diabetics (21 males, 84 females) with
primary thyroid failure. Of the patients with thyroid failure, 69 had
confirmed primary hypothyroidism and 36 had normal serum thyroxine con¬
centrations but persistently raised serum TSH concentrations. Group 2
included 164 insulin-dependent diabetics (37 males, 127 females) who had
normal serum TSH concentrations and no personal history of thyroid
disease. There was no significant difference between the two groups in
respect of age at time of study or duration of diabetes, as shown in
Table 13.
2
The data were submitted to x analysis.
The ocular fundi of each patient were carefully examined through
dilated pupils under clinic conditions and the retinopathy status
recorded 0 = no retinopathy; 1 = mild background retinopathy (small
number of microaneurysms and occasional blot haemorrhage); 2 = moderate
to extensive background retinopathy (large numbers of microaneurysms,
blot haemorrhages, hard or soft exudates or both); 3 = new vessel for¬
mation; 4 = blindness due to vitreous haemorrhage or retinal disorgani¬
sation, or both, after haemorrhage or fibrosis.
Results
Table 13 gives the retinopathy status of patients in the two groups
and shows no significant difference between them.
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Discussion
No significant difference in the prevalence or severity of retino¬
pathy was observed between insulin-dependent diabetics with and without
coexisting thyroid disease. Immune complexes, as found in patients with
autoimmune thyroid disease (Calder et al., 1974), most probably are not
contributing to the pathogenesis of diabetic microangiopathy. Other
immune complexes may well be responsible for the development of microan¬
giopathy (Di Mario et al., 1980) but they seem to be unrelated to the
coexistence of autoimmune thyroid disease.
These data do not support the hypothesis of Bottazzo et al.,
(1978b) that diabetes, associated with thyroid disease, is characterised
by an increased risk of the development of microangiopathy. This
hypothesis was based on the uncontrolled observation that retinopathy
was frequently encountered within a small number of diabetics with coin¬
cident thyroid disease. This was most probably a chance finding. More¬
over, the patients described had been diabetic for many years and might
have therefore been expected to be at increasing risk of microan¬
giopathy. A previous anecdotal description of apparent protection from
the development of microangiopathy had been reported by Glick (1961) in
a diabetic with associated cretinism. This further serves to confirm
the need to carry out an appropriately controlled investigation of the
risk of development of diabetic retinopathy and its putative relation¬
ship with coexisting thyroid disease. The present chapter describes
such a study which refutes the suggestion that coexisting thyroid
disease either protects against or increases the risk of diabetic
retinopathy.
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CHAPTER 8
HT.A antigen and serological determinants in diabetics with coexisting
thyroid disease.
The clinical characteristics of diabetics with coexisting thyroid
disease have previously been described (Chapter 6) and are distinct from
those of the general diabetic population, but are similar to those of
non-diabetics with autoimmune thyroid disease alone. Preliminary stu¬
dies have suggested that thyroid/diabetics may be distinguished from
subjects suffering only from diabetes or autoimmune thyroid disease on
the basis of their HLA type or serological profile. Thus, in a study
(Bottazzo et al., 1978a) of only 35 insulin-dependent diabetics with
coexistent thyroid disease, HLA-B8 was reported to be present in 83% of
thyroid/insulin-dependent diabetics - a figure almost twice that
reported in the general insulin-dependent diabetic population (Cudworth
and Wolf, 1982). No data have yet been published on the distribution of
HLA antigens in non-insulin-dependent diabetics with thyroid disease,
while the HLA antigen frequencies of hyperthyroid and hypothyroid dia¬
betics have yet to be compared in numbers of patients sufficient to pro¬
vide a meaningful answer. The frequency of islet cell, thyroid and gas¬
tric parietal cell antibodies in diabetics with associated thyroid
disease is also poorly characterised. The HLA and auto-antibody status
of a large group of such subjects has therefore been considered in the




Two hundred and forty three diabetics were studied including 177
insulin-dependent diabetics (30 males, 147 females) and 66 non-insulin-
dependent diabetics (9 males, 57 females), of whom 32 received sulpho-
nylureas, 22 biguanides and all of whom were on an appropriate diet.
Sixty-seven insulin-dependent diabetics and 27 non-insulin-dependent
diabetics were hyperthyroid, and 110 insulin-dependent diabetics and 39
non-insulin- dependent diabetics were hypothyroid (including 49
insulin-dependent and 10 non-insulin-dependent diabetics having per¬
sistently elevated serum TSH concentrations, but serum thyroxine concen¬
trations within the normal range). For hypertbyroid and hypothyroid
patients, combined, the mean ± SE ages at diagnosis of diabetes and
durations of diabetes at time of study were 38 ± 1.2 years and 18 ± 0.8
years in insulin-dependent diabetics and 59 ± 1.2 years and 5 ± 0.6
years in non-insulin-dependent diabetics. Mean ± SE ages at diagnosis
of thyroid disease and durations of thyroid disease were 39 ± 1.5 years
and 16 ± 1.3 years for hyperthyroid diabetics and 56 ± 1.1 years and 4 ±
0.4 years for hypothyroid diabetics, respectively.
Patients were treated with insulin if ketonuric, underweight and/or
unacceptably hyperglycaemic despite treatment with combined sulpho-
nylurea and biguanide therapy. All diabetics studied attended the Dia¬
betic and Dietetic Outpatient Department, Royal Infirmary, Edinburgh.
The clinical diagnoses of hyperthyroidism and primary hypothyroidism
were confirmed biochemically by current tests of thyroid function,
including estimation of plasma protein-bound iodine, effective thyroxine
ratio, total T4 and TSH concentrations and by means of the TSH stimula¬
tion test. Hyperthyroidism was shown to be due to Gravesx disease on
the basis of clinical, histological and/or radioisotope scanning
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evidence whereby patients with an overactive nodular goitre or other
cause of non-Graves * hyperthyroidism were excluded.
One hundred non-diabetic controls living in Edinburgh or its
environs were also studied with regard to HLA type, only.
Methods
Autoantibodies
Cytoplasmic islet cell (ICA) and complement fixing islet cell anti¬
bodies (CF-ICA) were detected as previously described (Irvine et al.,
1977e; Bottazzo et al., 1980). Thyroid microsomal antibodies and gas¬
tric parietal cell antibodies were detected by the indirect immu¬
nofluorescence technique using undiluted sera. Antibodies to thyroglo-
bulin were detected by means of the tanned cell haemagglutination tech¬
nique taking a titre of £25 as significant. Serum was available from
all patients.
HLA analyses
HLA typing was carried out in 143 insulin-dependent diabetics, 37
non-insulin- dependent diabetics and the controls by the standard
National Institute of Health (NIH) lymphocyte cytotoxicity technique
against a panel of 120 antisera defining the following locus A, B and C
specificities: HLA Al, 2, 28, 3, 9 (23, 24), 10 (25, 26), 11, 19, 29,
30, 31, 32, 33. HLA B5, 7, 8, 12, (44, 45), 13, 14, 15, 16, (38, 39),
17, 18, 21, (49, 50), 22, 27, 35, 37, 40, BW4 and BW6. HLAC CW3, CW4.
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Family History
A first degree family history of thyroid disease, insulin-dependent
or non-insulin-dependent diabetes was ascertained by means of a postal
questionnaire sent to each patient.
Statistics
2
Relationships between variables were tested by x analysis (with
Yates' correction) or Wilcoxon rank sum tests as appropriate. Multiple
logistic regression was used to test the relationship betwen presence of
ICA or CF-ICA and other factors including duration of diabetes.
RESULTS
Autoantibodies
ICA was detected in 60 (33%) insulin-dependent diabetics and 3 (4%)
non-insulin-dependent diabetics (p<0.001). There was no significant
difference in the prevalence of ICA when comparing hyperthyroid and
hypothyroid insulin-dependent diabetics (29 vs 37%) nor between male and
female insulin-dependent diabetics (17 vs 37%). Among hyperthyroid and
hypothyroid insulin-dependent diabetics, combined, the prevalence of ICA
2
declined with increasing duration of diabetes (x = 15.46, p<0.001), as
shown in Figure 4. The same relationship was found in respect of
2
hypothyroid, insulin-dependent diabetics (x = 15.74, p < 0.001), but
2
not in hyperthyroid, insulin-dependent diabetics (x = 0.99, NS) when
considered separately.
CF-ICA was detected in 34 (19%) insulin-dependent diabetics and 2
(3%) non-insulin-dependent diabetics (p<0.01). Only one CF-ICA positive
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patient was negative for ICA. There was no significant difference in
the prevalence of CF-ICA when comparing hyperthyroid and hypothyroid
insulin-dependent diabetics (21% vs 18%), nor between male and female
insulin-dependent diabetics (10 vs 21%). Among hyperthyroid and
hypothyroid insulin-dependent diabetics, combined, the prevalence of
CF-ICA declined with increasing duration of diabetes (x =6.12, p<0.05)
as shown in Figure 4. Hypothyroid insulin-dependent diabetics con¬
sidered separately showed a significant relationship between prevalence
2
of CF-ICA and duration of diabetes (x = 5.52, p<0.05), but hyperthyroid
2
insulin-dependent diabetics did not (x = 0.90, NS). Age at time of
study and duration of thyroid disease did not significantly influence
the prevalence of ICA/CF-ICA having taken account of the relationship
between prevalence of ICA/CF-ICA and diabetic treatment and duration of
diabetes.
2
Thyroid microsomal antibodies were more common (x = 25.16,
p<0.001) in hypothyroid (66%) than in hyperthyroid (32%) diabetics.
2
Thyroid microsomal antibodies were more common (x = 7.16, p<0.01) in
insulin-dependent diabetics (58%) than in non-insulin-dependent diabet¬
ics (38%). The same difference was evident when hyperthyroid and
hypothyroid patients were considered separately. Thus, thyroid micro-
2
somal antibodies were more common (x = 4.09, p<0.05) in hypothyroid
insulin-dependent diabetics (71%) than in hypothyroid non-insulin-
dependent diabetics (51%) and were likewise more common in hyperthyroid
insulin-dependent diabetics (31%) than in hyperthyroid non-insulin-




Thyreoglobulin antibodies were more common (x = 4.70, p<0.05) in
hypothyroid (17%) than in hyperthyroid (6%) diabetics, but were not more
common in insulin-dependent diabetics (12%) than in non-insulin-
dependent diabetics (14%). For a given diabetic treatment and thyroid
status, neither thyroid antibody showed a significant association with
duration of thyroid disease or of diabetes, ICA/CF-ICA status nor with
the sex nor age of the patient. The distribution of thyroid antibodies
was not related to sulphonylurea treatment in hypothyroid non-insulin-
dependent diabetics.
2
Gastric parietal cell antibodies were more common (x = 6.41,
p<0.05) in female (37%) than male (15%) diabetics, but did not relate
significantly to other autoantibody status, duration of diabetes/thyroid
disease, sex, diabetic treatment or thyroid status.
HLA Analyses
Table 14 shows the distribution of those HLA antigens which are
reported to be over- or under-represented in diabetics in this or previ-
2
ous studies. The prevalences of A1 and B8 were higher (x = 19.33,
2
p<0.01 and x =42.72, p<0.01) in thyroid/insulin-dependent diabetics
than controls and higher (x^ = 3.99, p<0.05 and x^ = 10.73, p<0.01) than
in thyroid/non-insulin-dependent diabetics. The prevalence of B7 was
2
lower (x = 11.32, p<0.01) in thyroid/insulin- dependent diabetics than
2
in controls, and lower (x = 5.64, p<0.05) than in thyroid/non-insulin-
dependent diabetics. There were no significant differences between
thyroid/non-insulin-dependent diabetics and controls in respect of HLA
antigen frequencies. HLA B8 was similarly prevalent in hyperthyroid
(61%) and hypothyroid (60%) diabetics (non-insulin-dependent and
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insulin-dependent diabetics, combined) and in hyperthyroid (69%) and
hypothyroid (65%) insulin-dependent diabetics. No HLA type was signifi¬
cantly related to age at onset of diabetes or of thyroid disease, nor to
any of the autoantibodies tested. In particular, the relationship
between prevalence of ICA/CF-ICA and duration of diabetes was not signi¬
ficantly different between HLA-B8 positive and negative subjects. ICA
and CF-ICA were present in 34% and 18% HLA-B8 positive patients and 26%
and 17% HLA-B8 negative patients.
Family histories
Family history questionnaires were completed by 94% insulin-
dependent diabetics and 94% non-insulin-dependent diabetics. A first
degree family history of insulin-dependent diabetes, non-insulin- depen¬
dent diabetes and thyroid disease was obtained from 20%, 9% and 19%
insulin-dependent diabetics and 20%, 30% and 18% non-insulin-dependent
diabetics. A positive family history of thyroid disease, insulin-
dependent or non-insulin-dependent diabetes was not significantly
related to autoantibody status, HLA type, age at diagnosis of diabetes
or of thyroid disease.
Follow-up of thyroid/non-insulin-dependent diabetics
Since the serology of these 66 patients was determined, they have
been followed up for 1-12 years (mean 3.2 years) in which time 5 (8%)
have required insulin teatment.
Discussion
Type 1 diabetes and autoimmune thyroid disease share histological,
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immunological, HLA antigen and familial characteristics as described in
Chapter 1. Common to both Graves' disease (Harvald and Hauge, 1956)
and type 1 diabetes (Barnett et al., 1981) is a concordance rate, in
identical twins, of approximately 50% implying a strong genetically
determined predisposition but also a role for an environmentally depen¬
dent aetiology. Where type 1 diabetes and autoimmune thyroid disease
are found together in the same patient, both conditions commonly occur
coincidentally, (Chapter 6) supporting the hypothesis of a shared under¬
lying pathogenesis. The latter appears to become less aggressive, in
respect of autoimmune beta cell destruction, with advancing age, since
thyroid/diabetics developing diabetes in late middle-age are frequently
non-ketonuric and non-insulin-dependent. Juvenile-onset
thyroid/diabetics, on the other hand, are usually insulin requiring
(Chapter 6). The prevalence of B8 in thyroid/insulin-dependent diabet¬
ics in this study (66%) is apparently greater than that described by
Cudworth and Woodrow (1976) in insulin-dependent diabetics without asso¬
ciated autoimmune disease (51%), but not as high as previously reported
(Bottazzo et al., 1978a) in a smaller series of thyroid/insulin-
dependent diabetics (83%). Similarly, the prevalence of B8 in
thyroid/insulin-dependent diabetics in this study is higher than has
been reported in non-diabetics with Graves' disease (40%; Mather et
al., 1980), atrophic hypothyroidism (53-57% ; Irvine et al., 1978b;
Moens et al., 1979) or Hashimoto's hypothyroidism (26-30%; Irvine et
al., 1978b; Moens et al., 1979). The present study shows that the pre¬
valence of B8 is similar in hypothyroid and hyperthyroid insulin-
dependent diabetics. It is possible that within the group of hypothy¬
roid diabetics, further heterogeneity with respect of HLA type might
- 88 -
have been evident in relation to whether patients had a goitre or not,
but such clinical data were not available. The over-representation of
HLA.-A1 in thyroid/insulin-dependent diabetics presumably reflects the
previously described linkage disequilibrium between A1 and B8 (Cudworth
and Woodrow, 1976). The reduced frequency of B7 in thyroid/insulin-
dependent diabetics is also similar to that described (Cudworth and Woo¬
drow, 1976) in the general insulin-dependent diabetic population. The
frequency of B15 was not increased in thyroid/insulin-dependent diabet¬
ics as has been reported (Cudworth and Woodrow, 1976) in the general
insulin-dependent diabetic population. It has been suggested (Rotter
and Rimoin, 1978) that two distinct genotypes (B8-DW3 and B15-DW4) are
associated with insulin-dependent diabetes and that only one of these
(B8-DW3) is commonly found in thyroid/diabetics. Our data are in accor¬
dance with such a hypothesis.
The prevalence of ICA in the thyroid/insulin-dependent diabetics is
clearly dependent upon duration of diabetes as shown in Figure 4. In
insulin-dependent diabetics without associated autoimmune disease, ICA
was demonstrated (Irvine et al., 1977e) in 56% and 7% of patients within
one year and more than five years from diagnosis of diabetes, respec¬
tively. The equivalent figures for thyroid/insulin-dependent diabetics
(77 and 30%) confirm our previous conclusion (Irvine et al., 1977e) that
the persistence of ICA is a feature of diabetics having coexistent
autoimmune disease. Neither the presence nor persistence of ICA is
related to the sex of the patient, nor family history of thyroid
disease/diabetes, nor type of thyroid disease (i.e. hyper- or hypothy¬
roidism) and no relationship was found between HLA type and ICA. Thus,
within the population of thyroid/insulin-dependent diabetics, the
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persistence of ICA was not associated with HLA-B8, as has previously
been described (Irvine et al., 1977e) in diabetics without overt autoim¬
mune disease. It is possible that of the latter group, those patients
demonstrating ICA persistence may subsequently have developed overt
autoimmune disease. The frequency of CF-ICA has not yet been well
characterised in the general diabetic population. Within
thyroid/insulin-dependent diabetics, the distribution of CF-ICA mimicked
that of ICA, declining in prevalence with increasing duration of dia¬
betes, but being found in only 56% of those patients positive for ICA.
Only one ICA negative patient was CF-ICA positive.
The HLA and serological characteristics of thyroid/non-insulin-
dependent diabetics are clearly very different from those of
thyroid/insulin-dependent diabetics. Thus, the HLA antigen distribution
of thyroid/non-insulin-dependent diabetics is not significantly dif¬
ferent from that of the control population and only the minority of
thyroid/non-insulin-dependent diabetics are positive for ICA or CF-ICA.
As such, it is very possible that thyroid/non-insulin-dependent diabet¬
ics are type 2 diabetics representing the chance coincidence of two
relatively common disorders - autoimmune thyroid disease and type 2 dia¬
betes. The low incidence of subsequent insulin dependency exhibited by
the thyroid/ non-insulin-dependent diabetics would appear to substan¬
tiate the view that these are type 2 diabetics. On the other hand,
thyroid/non-insulin-dependent diabetics tend to develop diabetes and
autoimmune thyroid disease coincidentally (Chapter 6) suggesting a com¬
mon underlying pathogenesis. Furthermore, the familial prevalence of
insulin-dependent diabetes and autoimmune thyroid disease is very high
in close relatives of thyroid/ non-insulin-dependent diabetics (Chapter
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10), implying that an inherited susceptibility to autoimmunity is opera¬
tive in such families. This predisposition appears not to be linked to
HLA-B8, and if the underlying pathogenesis of diabetes and thyroid
disease is uniform in such patients, and is immunologically mediated, it
is characterised by the relative absence of autoantibodies. Thus,
thyroid/non-insulin-dependent diabetics have significantly lower fre¬
quencies of ICA/CF-ICA and thyroid microsomal antibodies than
thyroid/insulin-dependent diabetics. The low frequency of thyroid
microsomal antibodies in thyroid/non-insulin-dependent diabetics cannot
be attributed to differences in age, duration of thyroid disease or sex
between the two groups of diabetics, and cannot be related to the
reported antithyroid effects of sulphonylurea treatment (Hunton et al.,
1965). The possibility, therefore, remains that thyroid/non-insulin-
dependent diabetics have an underlying diabetic pathogenesis of lesser
virulence, which is characterised by a less frequent or less sustained
humoral response than is found in thyroid/insulin-dependent diabetics,
leading to incomplete beta cell destruction. Other examples of autoim¬
mune diseases having varying degrees of severity and clinical expression
include Graves' disease whose course, after antithyroid drug therapy,
depends on HLA and serological determinants (Irvine et al., 1977b;
McGregor et al., 1980). Similarly, the natural history of autoimmune
thyroiditis is non-uniform and is related to serological factors as
described in Chapter 5.
Bottazzo et al (1978a) have suggested that thyroid microsomal anti¬
bodies are found in a higher proportion of hyperthyroid/insulin-
dependent diabetics (93%) than in uncomplicated hyperthyroid patients
(70%). Our findings do not confirm this difference with equivalent
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frequencies of 31% in hyperthyroid/insulin-dependent diabetics and 61%
in uncomplicated hyperthyroidism (Irvine et al., 1977d). Gastric parie¬
tal cell antibodies were found in thyroid/diabetics with a frequency
similar to that previously reported (Irvine et al., 1970) in the general
diabetic population, in whom the sex difference was again noted.
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DURATION OF DIABETES (years)
Fig. 4
Prevalences of ICA and CF-ICA, according to duration
of diabetes, in insulin-dependent diabetics with
coexisting autoimmune thyroid disease.
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Seasonal incidence of type 1 diabetes in diabetics with and without
autoimmune thyroid disease.
In 1926, Adams demonstrated "a seasonal variation in the onset of
acute diabetes" irrespective of sex and age at onset. He postulated
that this phenomenon might result from the seasonal variation in physi¬
cal activity and susceptibility to non-specific infection of an indivi¬
dual genetically predisposed to diabetes. A seasonal variation in the
incidence of insulin-dependent diabetes has since been confirmed in
patients presenting under the age of 20 years (Gamble and Taylor, 1969;
Christau et al., 1977; Bloom et al., 1975; Fishbein et al., 1982).
Where an attempt has been made (Gamble and Taylor, 1969) to show a sea¬
sonal variation in the incidence of insulin-dependent diabetes present¬
ing over the age of 20 years, the evidence is less convincing although
the decline in incidence during the early summer months remains evident
when all patients below the age of 30 years are considered together
(Christau et al., 1977), or when all patients are considered irrespec¬
tive of age at onset (Adams, 1926). If the seasonal variation in
incidence provides a clue to the aetiology of insulin-dependent dia¬
betes, it is necessary to establish which patients exhibit this
phenomenon. We have, therefore, examined the effects of sex and age at
onset on the pattern of seasonal incidence of insulin-dependent dia¬
betes, and have specifically considered insulin-dependent diabetics with
coexisting autoimmune thyroid disease to see whether they also exhibit a
seasonal variation in incidence.
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Patients and Methods
All patients with newly diagnosed diabetes who had been referred to
the Diabetic and Dietetic Department, Royal Infirmary, Edinburgh from
the city or its environs between 1964 and 1977 (inclusive) were con¬
sidered. Patients were regarded as insulin-dependent according to their
age at presentation, if under weight and/or ketonuric and only those
treated with insulin from diagnosis and for at least 6 months thereafter
were included. Patients with secondary diabetes, due to pancreatic
disease, endocrine disturbance or other causes were excluded. The study
did not include patients aged less than 10 years and many others aged 10
to 13 years who had been referred initially to a paediatric clinic. The
majority (i.e. almost 90%) of diabetics in Edinburgh attend the Diabetic
Department at the Royal Infirmary (Falconer et al., 1971) and will have,
therefore, been considered in our study. These included patients with
and without autoimmune thyroid disease, no attempt having been made to
segregate the two groups.
Five hundred and two patients (297 males, 205 females) were
included and analysed for the year and month of diagnosis and of symp¬
tomatic onset of diabetes. The duration of diabetic symptoms before
diagnosis had been obtained from all but nine patients. For the purpose
of further analyses, patients were sub-divided into three groups accord¬
ing to age at onset (10-19, 20-29 and more than 29 years).
Statistical analysis of the seasonal variation in incidence was
made by a test due to David and Newell (1965). The duration of symptoms
of diabetics of differing sex and age at onset were compared using Cox's
test for trend (Cox, 1970).
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Results
The age at diagnosis and sex distribution of the 502 diabetics stu¬
died are shown in Figure 5. The mean annual yield of newly-diagnosed
insulin-dependent diabetics was 14.8 (range 8-22) for patients aged 10-
19, 10.9 (range 5 - 19) for those aged 20-29 and 10.0 (range 6 - 15) for
those aged more than 29 years.
Figure 6A compares the seasonal variation in incidence of diagnosis
of diabetes in the three age groups where patients of both sexes were
combined. In patients aged 10 - 19 years at diagnosis, the incidence of
diagnosis was significantly greater during the winter months than during
the summer months (p<0.05). Patients aged 20-29 and more than 29 years
failed to show significant seasonal variation in the incidence of diag¬
nosis. When males and females aged 10-19 and more than 19 years (com¬
bining the patients aged 20-29 and more than 29 years at diagnosis) were
considered separately (Table 15), only the males aged 10 - 19 years
showed a significant seasonal variation in incidence of diagnosis
(p<0.05).
Figure 7 compares the duration of diabetic symptoms experienced by
diabetics of different sex and age groups. When the sexes were con¬
sidered together, the duration of symptoms of diabetics aged 10-19 years
was significantly shorter than that of diabetics aged 20-29 years
(p<0.02) and diabetics aged more than 29 years (p<0.0001). Women within
each age group had a longer duration of symptoms than men but the
difference was only statistically significant (p<0.05) in patients aged
20-29 years at diagnosis.
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Figure 6B shows a seasonal variation in symptomatic onset of dia¬
betes in 421 patients according to age at diagnosis, having exluded 72
patients whose symptoms had been present for more than three months
prior to diagnosis and nine patients whose duration of symptoms was unk¬
nown. In patients of both sexes combined, aged 10-19 years at diag¬
nosis, the incidence of symptomatic onset was again commoner during the
winter months than during the summer months (p<0.01). Patients of both
sexes combined aged 20-29 years and more than 29 years at diagnosis
failed to show a seasonal variation in symptomatic onset. When males
and females aged 10-19 and more than 19 years (combining the patients
aged 20-29 and more than 29 years at diagnosis) were considered
separately (Table 15), only the males aged 10-19 years showed a signifi¬
cant seasonal variation in incidence of symptomatic onset (p<0.05).
Discussion
Allowing for the fact that some younger teenagers and patients aged
less than 10 years are referred to paediatric clinics, the distribution
of age and sex at presentation of our patients is in accordance with
reports from other centres (Gamble and Taylor, 1969; Cudworth et al.,
1977), showing a slight male preponderance until middle age with female
preponderance in the older age groups. As with other studies, we
observed a seasonal variation in incidence of insulin-dependent diabetes
presenting between the ages 10-19 years - the incidence being higher
between the months of September and April inclusive. Previous investi¬
gation of patients presenting below the age of 6 years has revealed a
lack of seasonal variation in incidence (Bloom et al., 1975; McMillan et
al., 1977; Fishbein et al., 1982), while we have shown the same to be
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true of patients aged over 19 years at presentation.
A significant seasonal variation in incidence of insulin-dependent
diabetes might only be evident when duration of symptoms prior to diag¬
nosis is taken into account and those patients having a particularly
lengthy symptomatic onset excluded. Thus, the seasonal variation in
symptomatic onset is more marked than the seasonal variation in diag¬
nosis, when considering patients aged 10-19 years at presentation. Once
again, patients aged more than 19 years failed to show seasonal varia¬
tion in symptomatic onset, although it is evident that the duration of
symptoms prior to diagnosis increases with increasing age at onset of
diabetes. Such a prolonged interval between onset and diagnoses of dia¬
betes may obscure the seasonal variation in incidence as shown by the
younger patients whose duration of symptoms is relatively short.
A further important observation is that females do not demonstrate
a seasonal variation in diagnosis or symptomatic onset whichever age
category is considered, whereas males aged 10-19 years exhibit a signi¬
ficant seasonal variation in incidence. Duration of symptoms is con¬
sistently longer in females than male patients, and this may help to
obscure a true seasonal variation in incidence. Since the number of
female patients studied was relatively small, it might be argued that a
significant variation in incidence would emerge on examining a larger
population. However, Fishbein et al (1982) have recently reported
females to lack seasonal variation in incidence when examining 901 chil¬
dren aged less than 20 years at diagnosis. Males aged 5-14 years again
showed a significant seasonal variation in incidence.
If a variable seasonal incidence is regarded as supportive evidence
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of an environmentally induced aetiology, then male teenagers appear to
be particularly susceptible to this pathogenesis of insulin-dependent
diabetes. Lack of seasonal variation in incidence may imply an alterna¬
tive pathogenesis unrelated to environmental influences which may be
operative for female insulin-dependent diabetics. Indirect support for
this view derives from the observation that male animals are particu¬
larly vulnerable to pancreatic islet injury induced by streptozotocin
(Bonnevie-Nielsen et al., 1981), viral infections (Boucher et al., 1975;
Craighead and Higgins, 1974; Morrow and Craighead, 1980) and other com¬
pounds as found in smoked-cure mutton, (Helgason et al., 1982).
Since diabetics with associated autoimmune thyroid disease are usu¬
ally female and commonly late-onset, they might be expected not to show
a seasonal variation in incidence. In order to confirm this, a study
was undertaken of the month of diagnosis and of symptomatic onset in a
group of insulin-dependent diabetics with associated thyroid disease.
Patients and Methods
Those diabetics having coexisting autoimmune thyroid disease, (n =
83) who were treated with insulin from diagnosis ("primary" insulin-
dependent diabetics) and whose clinical features were described in
Chapter 5, were studied together with 33 patients (13 males, 20 females)
who were found to have persistently elevated serum TSH concentrations as
evidence of primary thyroid failure, the majority of whom had thyroid
autoantibodies. These patients were also treated with insulin from
diagnosis. The patients thus included 53 hyperthyroid patients whose
mean ±SE age at diagnosis of diabetes was 32.4 ± 13.9 years, and 63
patients with primary thyroid failure, whose mean age at diagnosis of
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diabetes was 38.2 ± 14.3 years.
Analysis of the seasonal variation in onset of diabetes was made by
the test of David and Newell (1965).
Results
Figure 8 compares the distribution of duration of diabetic symptoms
experienced by all "primary" insulin-dependent diabetics (including
patients with and without autoimmune thyroid disease) referred to the
Diabetic and Dietetic Department, Royal Infirmary, Edinburgh between
1964 and 1977 with that of "primary" insulin-dependent diabetics with
coexisting autoimmune thyroid disease referred to the same clinic. Only
patients treated with insulin from the outset were considered. It may
be seen that the two groups of patients had similar durations of symp¬
toms .
Figure 9A shows the seasonal incidence of diagnosis of diabetes in
"primary" insulin-dependent diabetics with coexisting thyroid disease.
Figure 9B shows the seasonal incidence of symptomatic onset of diabetes
in the same patients, having excluded those whose duration of symptoms
exceeded three months or had not been recorded. No significant seasonal
variation in incidence of diagnosis nor symptomatic onset of diabetes
was observed.
Discussion
The duration of diabetic symptoms at diagnosis is not significantly
longer in insulin-dependent diabetics with coexisting autoimmune thyroid
disease than in the general insulin-dependent diabetic population. Hav-
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ing allowed for the interval between the onset of symptoms and diagnosis
of diabetes, diabetics with associated thyroid disease do not exhibit a
seasonal variation in incidence, nor peaks in age at diagnosis of dia¬
betes as shown by Figure 5. There is therefore no epidemiological evi¬
dence to incriminate an environmentally determined aetiology in the
pathogenesis of diabetes when associated with autoimmune thyroid
disease, as provided by the clear seasonal variation in incidence of
male, teenager insulin-dependent diabetics. Analogous heterogeneity is
found amongst the pathologies of the thyroid gland such that patients
may suffer from viral subacute thyroiditis on the one hand and a variety
of autoimmune syndromes on the other hand. It seems likely that similar
heterogeneity may be found within the insulin-dependent diabetic popula¬
tion. Thus, a proportion of insulin-dependent diabetics may develop
insulitis as a result of a viral infection, the evidence for which is
outlined in Chapter 1. Such patients often develop diabetes in child¬
hood, are predominantly male, exhibit a seasonal variation in incidence
and show a higher prevalence of HLA4-B15 than older onset insulin-
dependent diabetics. Conversely, diabetics with associated thyroid
disease commonly develop diabetes in middle age, are predominantly
female, do not show any seasonal variation in incidence and show an
increased prevalence of HLA-B8. The aetiology of diabetes in such
patients may be determined by a true autoimmune pathogenesis unrelated
to environmental factors.
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Fig. 5
Age at diagnosis of diabetes and sex distribution of
patients studied.
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Distribution of duration of symptoms according to
age at onset and sex.
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Comparison of duration of symptoms of insulin-
dependent diabetics with coexisting autoimmune
thyroid disease with that of all insulin-dependent
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Family studies in diabetics with and without autoimmune thyroid disease.
In the preceding chapters the frequency with which insulin-
dependent diabetes and autoimmune thyroid disease coexist in the same
patient was described, and it was emphasised how such patients may be
distinguished from other diabetics without associated thyroid disease on
the basis of clinical, HLA antigen and serological determinants. Evi¬
dence was presented for an environmentally dependent aetiology in the
pathogenesis of some forms of insulin-dependent diabetes and the lack of
such evidence in diabetics having coexisting thyroid disease. Since
familial aggregation is a striking feature of other organ-specific
autoimmune diseases, the distribution of insulin-dependent diabetes in
close relatives of autoimmune diabetics (i.e. those with coexistent
autoimmune thyroid disease) might also be characteristic and distinct
from that of non-autoimmune diabetics (i.e. those without coexistent
autoimmune thyroid disease). In order to test this hypothesis, the pat¬
terns of inheritance of thyroid disease, insulin-dependent and non-
insulin-dependent diabetes in first degree relatives of diabetics with
and without coexisting autoimmune thyroid disease were compared.
PATIENTS AND METHODS
Diabetics with thyroid disease
Two hundred and thirty three unrelated diabetics (38 males, 195
females) were included who had clinically evident hyperthyroidism (n=86)
or primary hypothyroidism (n=115). The clinical diagnoses of hyperthy¬
roidism and primary hypothyroidism were confirmed biochemically by
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current tests of thyroid function, including estimation of plasma
protein-bound iodine, effective thyroxine ratio, total thyroxine and
thyrotrophin (TSH) concentrations and by means of the TSH stimulation
test. Hyperthyroidism was shown to be due to Graves' disease on the
basis of clinical, histological and/or radioisotope scanning evidence
whereby patients with an overactive nodular goitre or other cause of
non-Graves' hyperthyroidism were excluded. Thirty two patients with
clinically unrecognised impaired thyroid reserve, having persistently
elevated plasma TSH concentrations (>5.7mu/l.), were also included.
Since the majority of diabetics with primary thyroid failure have circu¬
lating thyroid auto-antibodies, the aetiology of hypothyroidism may be
considered to be autoimmune thyroiditis.
Diabetics without thyroid disease
Four hundred and ten unrelated diabetics (159 males, 251 females)
were included who had no previous history of thyroid disease and who had
been shown to have a normal plasma TSH concentration. These were
selected on the basis that they should be of similar age, diabetic dura¬
tion and diabetic treatment as the diabetics with thyroid disease.
All diabetics attended the Diabetic and Dietetic Out-Patient
Department at the Royal Infirmary, Edinburgh.
Controls
Five hundred and eight healthy volunteers (277 males, 231 females)
were included, who had no medical history of diabetes or thyroid
disease. They comprised 98 males, aged 40-59 years, who were attend¬
ing the Heart Disease Prevention Clinic, 111 females, aged 40-59 years,
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who were attending the Edinburgh Breast Screening Clinic and 299 blood
donors (179 males, 120 females) who were selected on the basis that they
should be of similar age to the diabetic groups.
A postal questionnaire was sent to all participants asking the
number of siblings and children in each participant's family and whether
any first degree relatives were known to have had an overactive or
underactive thyroid gland, insulin-dependent or non-insulin-dependent
diabetes. Age at onset of diabetes in affected relatives was also
asked. A brief summary of the respective symptoms and likely treat¬
ments of each condition was provided. In order to validate the reported
status of diabetic relatives of diabetic propositi, an attempt was made
to examine the hospital records of all such diabetic relatives attending
the Diabetic and Dietetic Outpatient Department, Royal Infirmary, Edin¬
burgh. Records for 54 (51%) of the 105 diabetic relatives of diabetics
with thyroid disease and 52 (37%) of the 140 diabetic relatives of dia¬
betics without thyroid disease were available. All such patients were
confirmed to be diabetic and their treatment had been correctly reported
by postal questionnaire in every case.
Statistical analysis
Statistical comparisons of the prevalence of affected relatives
among the various groups of propositi were complicated by the fact that
the propositi had variable numbers of siblings and children at risk.
Thus the denominators for the proportions of affected siblings and chil¬
dren given in Tables j"J, if and22^are the total numbers of the particular
type of relative in each group, and not the numbers of propositi in the
groups. A simple comparison of proportions between two groups by a 2x2
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and non-autoimmune groups of propositi each showed male preponderance in
children and female preponderance in siblings and parents. When all
insulin-dependent relatives were considered together, the male to female
ratio in children (5.66:1) exceeded that (0.68:1) of siblings and
2
parents combined (X =12.25, p<0.001). This difference might be due
to males developing insulin-dependent diabetes at a younger age than
females. However, mean age at onset of insulin-dependent diabetes in
affected relatives was similar in males and females when each generation
was considered separately (Table 20). The sex ratio (M:F) of insulin-
dependent diabetic propositi with insulin-dependent diabetic sons (4:9)
was not significantly different from that (2:1) of those with insulin-
dependent diabetic daughters.
The sex of the propositus did not significantly influence the pre¬
valence of insulin-dependent diabetes in first degree relatives, which¬
ever generation of relative or study group was considered.
Table 21 compares the observed and expected prevalences of
insulin-dependent diabetes in parents of the five study groups, based on
the observed prevalence in siblings . The observed exceeded the
2
expected prevalence when considering parents of controls (X =5.22,
p<0.05) or those of all subjects without a personal/family history of
2
thyroid disease (X = 9.76, p<0.001). In contrast, the expected
2
exceeded the observed prevalence, albeit not significantly so (X =
2.24), when considering parents of insulin-dependent and non-insulin-
dependent diabetics with a personal/ family history of thyroid disease.
Comparison of the ratios of observed to expected prevalence of insulin-
dependent diabetes in parents of subjects with and without a
-in¬
difference was observed.
2. Family history of insulin-dependent diabetes.
Of 266 diabetics with a personal history (n=233) or only a first
degree family history (n=33) of thyroid disease, 179 were insulin-
dependent and 87 were non-insulin-dependent. Diabetics with neither a
personal nor first degree family history of thyroid disease included 245
insulin-dependent and 111 non-insulin-dependent patients.
Table 19 shows the distribution of insulin-dependent diabetes in
relatives of the five study groups. Insulin-dependent diabetes was
2
less common (X =7.52, p<0.01) in mothers of controls than mothers of
insulin-dependent diabetics without a personal/family history of thyroid
disease. With this exception, the prevalence of insulin-dependent dia¬
betes was similar in parents and children of the five study groups.
The prevalence of insulin-dependent diabetes in siblings of
insulin-dependent diabetics with a personal/family history of thyroid
2
disease was greater (X = 7.71, p<0.01) than that of insulin-dependent
diabetics without a personal/family history of thyroid disease which
2
was, in turn, greater (X = 8.81, p<0.01) than that of controls. The
prevalence of insulin-dependent diabetes in siblings of non-insulin-
dependent diabetics with a personal/family history of thyroid disease
2
was greater (X = 6.53, p<0.05) than that of non- insulin-dependent dia¬
betics without a personal/family history of thyroid disease and greater
2
(X =7.95, p<0.01) than that of controls.
Table 20 compares the sex ratios of insulin dependent diabetic
relatives of autoimmune and non-autoimmune propositi. The autoimmune
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thyroid disease, 17 (12%) were male, with an overall female to male
ratio of 7.2:1. On the other hand, the prevalences of thyroid disease
in relatives of male and female propositi were similar.
The reported prevalences of hyperthyroidism and hypothyroidism in
relatives of the five study groups were similar and are reflected by the
overall figures for thyroid disease shown in Table 17. Of 139 affected
relatives, 90 (65%) were hyperthyroid and 49 (35%) were hypothyroid.
The reported prevalences of hyperthyroidism and hypothyroidism amongst
first degree relatives of hyperthyroid propositi (18% and 6%) were not
significantly different from those (15% and 12%) amongst relatives of
hypothyroid propositi.
The question was then considered as to whether thyroid disease was
found in similar prevalence in successive generations of relatives of
the study groups. Given the observed prevalence of thyroid disease in
siblings of propositi, it is possible to estimate the expected pre¬
valence in parents, although it must be remembered that this is a con¬
servative estimate since parents will be older than siblings and will
therefore be at greater risk of having developed thyroid disease. Table
18 shows a comparison between the observed and expected prevalences of
thyroid disease in parents of subjects in the five study groups. In con¬
trast to the other groups, the observed prevalence was lower than
expected in respect of parents of insulin-dependent diabetics with thy-
2
roid disease (X = 4.36, p<0.05) and non-insulin-dependent diabetics
with thyroid disease (N.S.). However, when parents of all subjects
with and without thyroid disease were compared in respect of ratio of
observed to expected prevalence of thyroid disease, no significant
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145 were insulin-dependent and 82 were non-insulin-dependent. Diabetics
without thyroid disease included 279 insulin-dependent and 116 non-
insulin-dependent patients. The characteristics of all participants (n
= 1100) in the 5 study groups are shown in Table 16.
1. Family history of thyroid disease
Table 17 shows the distribution of thyroid disease in relatives of
the five study groups. Thyroid disease was of similar prevalence in
parents and children of the five groups.
The prevalence of thyroid disease in siblings of insulin-dependent
and non-insulin-dependent diabetics with coexisting thyroid disease were
similar and greater (X^ = 6.80, p<0.01 and = 3.95, p<0.05) then that
of insulin-dependent diabetics without thyroid disease. The prevalence
of thyroid disease in siblings of insulin-dependent diabetics without
2 2
coexisting thyroid disease was greater (X =4.83, p<0.05 and X =6.00,
p<0.05) than those of non-insulin-dependent diabetics without thyroid
disease and controls, which were similar.
Twenty-nine (20%) insulin-dependent diabetics with thyroid disease,
21 (26%) non-insulin-dependent diabetics with thyroid disease, 34 (12%)
insulin-dependent diabetics without thyroid disease, 5 (4%) non-
insulin-dependent diabetics without thyroid disease and 28 (6%) controls
had a first-degree family history of thyroid disease.
Consistent female preponderance amongst relatives having thyroid
disease was noted, irrespective of propositus group, generation of rela¬
tive or type of thyroid disease (hyperthyroid or hypothyroid) affecting
the propositus or affecting the relative. Of 139 relatives with
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contingency table analysis is therefore invalid, since some of the indi¬
viduals making up the totals belong to the same family and so are not
independent. In particular, a situation in which the chance of an indi¬
vidual being affected by (say) thyroid disease was strongly dependent on
familial factors but was independent of diabetic status could result in
a spurious significance in a comparison of prevalence of thyroid disease
in the relatives of two different groups of propositi classified by dia¬
betic status. It was therefore necessary to analyse the prevalence
data by comparing the proportions of propositi reporting at least one
affected relative. Clearly the chance of a propositus doing so will
depend both on his or her own age and on the number of that type of
relative he or she has, as well as (perhaps) on his or her own disease
status. Multiple logistic regression analysis was therefore used to
test whether the different groups of propositi differed in their proba¬
bilities of reporting affected relatives once the effects of age and
family size were accounted for. The age and familiy size effects were
in fact quite significant in many of the analyses, suggesting that the
use of this method was indeed necessary. For parental prevalence, only
the age effect was included, since the number of parents per propositus
is of course constant. The method results in an approximate chi-
squared statistic with one degree of freedom when two groups are com¬
pared.
The prevalence of affected parents and siblings was also compared
within groups (Tables 18, 21 and 23) by a method involving the calcula¬
tion of the expected number of affected parents under the hypothesis
that parents and siblings are equally likely to be reported as affected.
The method is described here for a comparison of mothers with sisters.
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For a propositus with n sisters and r affected female relatives in the
parental and sibling generations, the probability of the mother being
affected is r/(n+l) if mothers and sisters are equally likely to be
affected. Thus the number of affected mothers for that propositus has
2
expected value r/(n+l) and variance r(n+l-r)/(n+l) , and the expected
values and variances can be summed over a group of propositi and com¬
pared to the observed number of affected mothers by the following
statistic:
2
(lobserved - sum of expecteds|-1) /(sum of variances),
which is distributed approximately as chi-squared with one degree of
freedom under the null hypothesis. This test is clearly conservative
for testing excess prevalence in siblings, since they will be less
likely to be reported as affected, being younger than the parents, even
if the null hypothesis is true. The degree of excess prevalence in
siblings as compared to parents was tested between groups by a strati¬
fied analysis, in which the proportions of affected parents were com¬
pared in a series of 2x2 tables with fixed _r and ii and then combined to
give a single chi-squared statistic.
Other analyses were done using ordinary chi-squared tests (sex
ratios in different groups) or Wilcoxon rank sum tests (ages at onset in
different groups).
RESULTS
Satisfactorily completed questionnaires were returned by 227 (97%)
diabetics with thyroid disease, 395 (96%) diabetics without thyroid
disease and 478 (94%) controls. Of 227 diabetics with thyroid disease,
- 116 ~
personal/family history of thyroid disease showed a highly significant
iifference (X^ = 9.92, p<0.01).
3. Family history of non-insulin-dependent diabetes
A personal or family history of thyroid disease did not signifi¬
cantly influence the probability of a diabetic having a first degree
relative with non-insulin-dependent diabetes. Therefore, for the fol¬
lowing analyses, all insulin-dependent diabetics, irrespective of thy¬
roid status, were combined, as were all non-insulin-dependent diabetics.
Table 22 shows the reported prevalence of non-insulin-dependent
iiabetes in relatives of the three study groups. No significant differ¬
ence was observed among fathers of the three groups. The prevalence of
lon-insulin-dependent diabetes in mothers of non-insulin-dependent dia-
2
eetics was greater than those of insulin-dependent diabetics (X =
L0.49, p<0.01) and controls (X^ = 19.08, p<0.001), which were similar.
The prevalence of non-insulin-dependent diabetes in siblings of
2
lon-insulin-dependent diabetics was greater (X =11.12, p<0.001) than
2
:hat of insulin-dependent diabetics, which was greater (X = 5.73,
><0.05) than that of controls. The prevalences of non-insulin-
lependent diabetes in children of the study groups were not signifi¬
cantly different.
Consistent female preponderance was noted among non-insulin-
lependent diabetic relatives of insulin-dependent diabetics (15 males,
>1 females), non-insulin-dependent diabetics (27 males, 40 females) and
controls (8 males, 14 females). Table 23 compares the sex ratios of
ion-insulin-dependent diabetic relatives in different generations for
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all three study groups combined. The male to female ratio was greater
2
(X =6.25, p<0.05) in children than in siblings and parents combined.
Mean age at onset of non-insulin-dependent diabetes in affected rela¬
tives was similar in males and females within each generation.
Table 24 compares the observed and expected prevalences of non-
insulin-dependent diabetes in parents of the three study groups, based
on the observed prevalence in siblings. The observed exceeded the
2
expected prevalence when considering parents of controls (X =3.85,
p<0.05) but not parents of insulin-dependent or non-insulin-dependent
diabetics. No significant difference was observed between the three
study groups in respect of the ratio of observed to expected prevalence
of non-insulin-dependent diabetes in parents.
DISCUSSION
Evidence for genetic heterogeneity of insulin-dependent diabetes
was originally provided by the observation that relatives of diabetics
with thyroid antibodies are, themselves, more likely to have thyroid
antibodies than those of diabetics without thyroid antibodies (Nissley
et al., 1973; Fialkow et al, 1975). This distinction is supported by
the present study which shows that diabetics with coexisting thyroid
disease are more likely to report a first degree family history of thy¬
roid disease than diabetics without coexisting thyroid disease. More¬
over, the familial aggregation of thyroid disease is most evident when
considering siblings of the propositi. Patients with a personal thy¬
roid history may take a particular interest in the distribution of thy¬
roid disorders in close relatives, and our findings may merely reflect
bias in the familial ascertainment rate of thyroid disease. However, it
-
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seems unlikely that a significantly higher ascertainment rate should be
selectively operative for siblings. A similarly increased frequency of
thyroid disease in siblings (who were predominantly female) compared
with other first degree relatives of non-diabetics with Graves' disease
has previously been reported (Bartels, 1941; Martin and Fisher, 1945).
The best fitting genetic theory to explain this finding was offered to
be a 'single-recessive, autosomal type of inheritance with relative lim¬
itation to women and a reduced penetrance rate of 70 to 80% in homozy-
gotes' (Bartels, 1941). In the absence of reliable comparative data
for non-diabetic hypothyroid patients, it would appear that the coex¬
istence of diabetes has little influence on the familial distribution of
thyroid disease. Female preponderance is a feature of affected rela¬
tives with thyroid disease as it is of diabetic probands (Chapter 6) and
non-diabetic probands (Tunbridge et al., 1977a) with thyroid disease.
The relatives of hyperthyroid and hypothyroid propositi seem to be simi¬
larly susceptible to both hyper- and hypothyroidism, there being no ten¬
dency for either condition to 'breed true'. An increased susceptibil¬
ity to thyroid disease was observed in the relatives of both insulin-
dependent and non-insulin-dependent diabetics with thyroid disease, sug¬
gesting that the families of both groups of diabetics were equally
predisposed to "autoimmunity". A further proportion of insulin-
dependent diabetics having no personal thyroid history have a first
degree family history of thyroid disease and may, on this account, also
be regarded as having autoimmune diabetes. In spite of the recognised
association between clinical thyroid disease and type I diabetes, family
studies have indicated that type I diabetes and thyrogastric autoimmun¬
ity have differing genetic determinants (Gorsuch et al., 1980). Thus,
- 119-
it is not surprising that autoimmune type 1 diabetics without thyroid
disease may yet have a strong thyroid family history. Non-insulin-
dependent diabetics without thyroid disease exhibit a thyroid family
history indistinguishable from that of controls, confirming that the
aetiologies of non-insulin-dependent diabetes and thyroid disease are
unrelated.
Insulin-dependent diabetes is more commonly reported in siblings of
autoimmune diabetics than in those of non-autoimmune diabetics. This
observation is unlikely to be related to ascertainment bias and there¬
fore represents another clinical feature of autoimmune diabetics which
is at variance with those of the general diabetic population. Further¬
more, it adds support to the view that inherited factors are strongly
implicated in the pathogenesis of autoimmune diabetes as with other
autoimmune disorders. When comparing the prevalences of insulin-
dependent diabetes in siblings of the study groups, autoimmune non-
insulin-dependent diabetics lie between autoimmune and non-autoimmune
insulin-dependent diabetics and are significantly different from non-
autoimmune non-insulin-dependent diabetics and controls. This suggests
that some of the autoimmune non-insulin-dependent diabetics are type 1
diabetics although non-insulin-dependent. Some autoimmune non-insulin-
dependent diabetics undoubtedly represent type 2 diabetics having coex¬
isting autoimmune thyroid disease - the inevitable, randomly deter¬
mined coincidence of two relatively common disorders.
The prevalence of insulin-dependent diabetes in siblings of
insulin-dependent diabetics without a personal/family history of thyroid
disease was greater than that of controls suggesting that inherited fac-
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tors also play a role in the pathogenesis of non-autoimmune insulin-
dependent diabetes. This difference might be due to ascertainment bias.
However, there was no significant difference in prevalence of insulin-
dependent diabetes when comparing the relatives of non-insulin-dependent
diabetics without a personal/family history of thyroid disease and con¬
trols. The latter finding further serves to confirm that the risks of
developing insulin-dependent and non-insulin-dependent diabetes are
inherited independently of one another.
As might be predicted from their greater age, the prevalence of
insulin-dependent diabetes in parents of non-autoimmune propositi
exceeded that of siblings. In contrast, and despite the age difference
between parents and siblings, the prevalence of insulin-dependent dia¬
betes in siblings exceeded that of parents of autoimmune propositi,
there being a significant difference between autoimmune and non-
autoimmune propositi in the ratio of observed to expected prevalence in
parents, based on the observed prevalence in siblings. The excessive
susceptibility to insulin-dependent diabetes exhibited by siblings of
autoimmune diabetic propositi is very similar to the higher prevalence
of thyroid disease in siblings of propositi with Graves' disease as
reported in this and other studies (Bartels, 1941; Martin and Fisher,
1945). Thus, not only is the heritability of insulin-dependent diabetes
increased in siblings of autoimmune diabetics, but also the pattern of
inheritance may be distinguished from that found in the general diabetic
population and may represent a characteristic feature of organ-specific
autoimmune diseases.
Male preponderance in insulin-dependent diabetic offspring of dia-
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betic propositi was a feature of both autoimmune and non-autoimmune dia¬
betics. This apparent sex imbalance requires to be confirmed by extend¬
ing the number of propositi studied and may simply reflect the previ¬
ously reported (Bloom et al., 1975) male preponderance of the young,
insulin-dependent diabetic population whose sex ratio reverses with
increasing age at onset (Chapter 9). Accordingly, as the children of
diabetic propositi grow older, a greater proportion of daughters than
sons may develop insulin-dependent diabetes. Alternatively, these
findings might be related to the observation (Cudworth et al., 1979) (as
yet unconfirmed) that male children are more likely than female children
to inherit the HLA A1-B8 haplotype which is known to confer susceptibil¬
ity to type 1 diabetes.
The relatives of non-insulin-dependent diabetics had a higher pre¬
valence of non-insulin-dependent diabetes than those of controls and
insulin-dependent diabetics, in accordance with previous studies (Irvine
et al., 1977c; Gottlieb, 1980; Tattersall and Fajans, 1975). Coexist¬
ing thyroid disease in propositi had no influence on the familial pat¬
tern of non-insulin-dependent diabetes confirming that thyroid disease
and non-insulin-dependent diabetes have unrelated aetiologies. That
insulin-dependent diabetics reported a higher prevalence of non-
insulin-dependent diabetes in siblings than did controls suggests the
possibility that some insulin-dependent propositi were type 2 diabetics
and/or that some non-insulin-dependent relatives were type 1 diabetics.
Ascertainment bias might equally explain this observation. As with the
families of insulin-dependent diabetics, the male preponderance of non-
insulin-dependent diabetic children as compared with siblings and
parents may be of doubtful significance, particularly in view of the
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very small number of children reported to have non-insulin-dependent
diabetes. Important environmental influences may also distort the sex
ratios of the different generations of relatives, including obesity and
parity. Moreover, the familial frequency of non-insulin-dependent dia¬
betes as reported by propositi is likely to underestimate the true pre¬
valence, as has previously been shown (Keen and Track, 1968).
In accordance with other reports, this study confirms that
insulin-dependent and non-insulin-dependent diabetes are inherited
separately and that some type 1 diabetics (i.e. non-insulin-dependent
diabetics with a personal or family history of thyroid disease) are not
necessarily insulin-treated. Heterogeneity with respect to the pattern
of inheritance of insulin-dependent diabetes clearly exists within the
type 1 diabetic population. Autoimmune diabetics demonstrate greater
inherited susceptibility to insulin-dependent diabetes than non-
autoimmune diabetics, with siblings being at greatest risk. Autoimmune




Insulin-dependentd ab tics withthyroiddisease (n=lU5)
Age(yr)
57±1.1
Non-insulin-dependentdiab tics withthyroiddisease66±1.1 (n=82) Insulin-dependentdiabetics withoutthyroiddisease (n=279)
58±0.7
Non-insulin-dependentdiab tics withoutthyroiddisease6U±0.9 (n=ll6) Controls (n=i+78)
Durationof DiabetesS xRatio (yr) 17±0.9 6±0.6 18±0.6 7±0.6
(M:F)
56±0,k
0.20I 0.19 0.90j 0.22 l.lU
Number of
SiblingsChildren 2.8+0 2l.b±1 3.2±0.32.50 3 2.9±0 11 6 3.0±0 21.8/± 2.0±0 11 U
Dataexpressedm n±S.E.
TABLEIT
Reportedreval nce(%)fthy oidis sinfirstd greeelativ s ofparticipantsinthefivs udygroups FatherMot r
1.Insulin-dependentdiabetics withthyroiddisease (n=lU5) 2.Non-insulin-dependent diabeticswiththyroid disease (n=82) 3.Insulin-dependentdiabetics withoutthyroiddisease (n=279) Non-insulin-dependent diabeticswithoutthyroid disease (n=ll6) 5.Controls (n=U78) 1.vs2 1.•vs3 3.vsb 3.vs5
0.7 0.3 0.8 NS NS NS NS
U .8 b.9 U.7 1.7 2.7 NS NS NS NS
Brother 3.0 0.9 0.5 0.2 NS
X' p<0.05 NS NS
Sister 10.7 10.1 b.5 0.6 2.0 NS
p<0.05 x2=5.18,
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Sex ratio of insulin-dependent diabetic relatives of
autoimmune and non-autoimmune propositi
Autoimmune propositi* Non-autoimmune propositi+
Male Female Male Female
Parents 1+ (1*2) 13 (52) 20 (57) 25 (53)
Siblings 19 (33) 25 (35) 11 (U2) 17 (1+6)
Children 8 (16) 1 (11+) 9 (12) 2 (9)
Mean age at onset of diabetes in parenthesis
* Insulin-dependent and non-insulin-dependent diabetics with personal/family
history of thyroid disease.
+ Insulin-dependent and non-insulin-dependent diabetics without personal/
family history of thyroid disease, and controls.
TABLE21
Comparisonofbservedandex ected*pr valences insulin-dependentd abetesparentsofthparticipants inthefivstudygroups ObservedExpected
Variance
xSignificance




13.1*8 5.8 10.35 U.17 6.17
6.76 3.1*2 6.02 2.36 3.59
3.67 2.86 0.75






Reportedprevalence(%)ofnon-insulin-dependentdiab t s infirstdegreerelativesofinsulin-d pendentdiab tics, non-insulin-dependentdiabeticscontrol FatherMother
1.Insulin-dependentdiab tics (n=U2U) 2.Non-insulin-dependentdiabetics (n=198) 3.Controls (n=U78) 1.vs2 1.vs3 2.vs3
1.13.0 3.09.6 1.29 NSx2=10.U9, p<0.01 NS NSx2=19.08, p<0.01
Brother 1.5 6.1 0.2
.2=
=9.71+,
p<0.01 NS x2=13.11+, p<0.001
Sister 2.8 6.6 0.9 NS NS
x2=7.02, p<0.01
Sibling 2.2 6.1+ 0.5
x2=11.12, p<0.001 x2=5.73, p<0.05 x2=23.56, p<0.001









Sex ratio of non-insulin-dependent diabetic
relatives of all participants
Male Female
Parents IT (67) kl (6k)
Siblings 28 (57) kk (57)
Children 5 (38) 0
Mean age at onset of diabetes in parenthesis
TABLE 2k
Comparison of observed and expected* prevalences of




Insulin-dependent diabetics lU 13.13 7.67 0.02 NS
Non-insulin-dependent diabetics 16 16.37 9M 0.00 NS




Insulin-dependent diabetes and autoimmune thyroid disease show
similar histological, immunological and HLA antigen characteristics.
Animal models of each condition arise spontaneously and concomitantly,
and may be induced by immunisation with pancreatic islet and thyroid
tissue, respectively.
This thesis shows that the prevalence of clinically recognised
autoimmune thyroid disease is three times more common amongst insulin-
dependent than amongst non-insulin-dependent diabetics. Similarly,
clinically unrecognised primary autoimmune thyroid failure, as evidenced
by elevation of the serum thyrotrophin concentration, is twice as common
amongst insulin-dependent than amongst non-insulin-dependent diabetics.
Elevation of the serum thyrotrophin concentration is usually accompanied
by thyroid microsomal antibodies. In antibody positive patients with an
elevated thyrotrophin concentration but serum total thyroxine concentra¬
tion within the normal range, hypothyroidism develops at a rate of 5%
per annum. These observations suggest that autoimmune thyroid disease
and insulin-dependent diabetes may share a common aetiology. In
patients suffering from both diabetes and autoimmune thyroid disease,
the two conditions are often diagnosed concomitantly suggesting both a
common and coincident pathogenesis.
Autoimmune thyroid disease represents a heterogeneous group of
diseases including Hashimoto's thyroiditis, primary atrophic hypothy¬
roidism and Graves' disease each having distinct clinical, histological,
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immunological and HLA antigen characteristics. Similarly, within the
insulin-dependent diabetic population, patients with coexisting auto¬
immune thyroid disease differ from patients without coexisting auto¬
immune thyroid disease by exhibiting marked female preponderence, late
age at onset of diabetes, increased frequency of HLA-B8 and of cyto¬
plasmic and complement fixing islet cell antibodies. Thus, clinical HLA
antigen and immunological heterogeneity is a feature both of insulin-
dependent diabetes and autoimmune thyroid disease.
Identical twin studies of insulin-dependent diabetes show a concor¬
dance rate of 50% suggesting the aetiology of this condition to be
dependent both upon inherited and environmental factors. Further evi¬
dence for an environmental precipitant to the development of insulin-
dependent diabetes derives from the peak ages of incidence of this con¬
dition, which may be associated with exposure to new infective agents,
together with its variable seasonal incidence. This thesis has con¬
firmed the variable seasonal incidence of male, teenage, insulin-
dependent diabetes. This observation is in accordance with the reported
predilection of environmentally induced experimental diabetes for male
animals. In contrast, no such seasonal variation in incidence nor peaks
in age incidence were observed in insulin-dependent diabetics with coex¬
isting thyroid disease suggesting their diabetic aetiology to be
independent of the environment. Conversely, a personal or family his¬
tory of thyroid disease in a diabetic increases the chance of that
patient having an insulin-dependent diabetic sibling, suggesting that
inherited factors may play a predominant role in the aetiology of dia¬
betes when associated with thyroid disease. It is therefore proposed
that environmental factors are largely responsible for the development
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of insulin-dependent diabetes in younger, male patients, while inherited
factors, possibly leading to autoimmunity, may predispose to insulin-
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